USP订购编号 | 美国药典,USP分析标准品,英文名称,规格 | CAS编号查询 | UN编号对照 |
USP-1062020 | Benzyl Disulfide (200 mg) | 150-60-7 | |
2930902000 | |||
USP-1065209 | Berberis aristata Stem Dry Extract (100 mg) | NA | |
1302190200 | |||
USP-1065210 | Berberine Chloride (50 mg) | 141433-60-5 | |
2939790000 | |||
USP-1065221 | Bendamustine Hydrochloride (200 mg) | 3543-75-7 | UN2811 |
USP-1065232 | Bendamustine Related Compound A (25 mg) (4-{5-[Bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid hydrochloride) | 109882-29-3 | |
2933998350 | |||
USP-1065243 | Bendamustine Related Compound B (20 mg) (4-(1-Methyl-5-morpholino-1H-benzimidazol-2-yl)butanoic acid hydrochloride) | N/A | |
2934990005 | |||
USP-1065254 | Bendamustine Related Compound C (20 mg) (Ethyl 4-{5-[bis(2-hydroxyethyl)amino]-1-methyl-1H -benzimidazol-2-yl}butanoate) | 3543-74-6 | |
2933998350 | |||
USP-1065265 | Bendamustine Related Compound D (20 mg) (4-{5-[(2-Chloroethyl)amino]-1-methyl-1H -benzimidazol-2-yl}butanoic acid hydrochloride) | 1797881-48-1 | |
2933998350 | |||
USP-1065276 | Bendamustine Related Compound E (20 mg) (4-{5-[(2-Chloroethyl)(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid) | 109882-27-1 | |
2933997500 | |||
USP-1134288 | Citalopram Related Compound E (25 mg) (1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile-N-oxide hydrochloride) | 62498-71-9 | |
2932996560 | |||
USP-1134299 | Citalopram Related Compound F (200 mg) (dimethyl-(1-methyl-3,3-diphenyl-allyl)-amine hydrochloride) | 55011-89-7 | UN2811 |
USP-1134305 | Citicoline Sodium (2 x 350 mg) | 33818-15-4 | |
2934990005 | |||
USP-1134313 | Ciprofloxacin (200 mg) | 85721-33-1 | UN3077 |
USP-1134324 | Ciprofloxacin Ethylenediamine Analog (25 mg) (1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-[(2-aminoethyl)amino]-3-quinolinecarboxylic acid hydrochloride) | 528851-31-2 | |
2933497050 | |||
USP-1152600 | Cyclamic Acid (100 mg) | 100-88-9 | |
2929909000 | |||
USP-1152701 | Cyclandelate (200 mg) | 456-59-7 | |
2918191350 | |||
USP-1152814 | Cyclic Olefin Polymer (1 g) | N/A | |
3902900050 | |||
USP-1154004 | Cyclizine Hydrochloride (200 mg) | 303-25-3 | UN2811 |
USP-1154503 | Cyclobenzaprine Hydrochloride (200 mg) | 6202-23-9 | |
2921490002 | |||
USP-1235106 | Emtricitabine (200 mg) | 143491-57-0 | |
2934990005 | |||
USP-1235128 | Emtricitabine System Suitability Mixture A (15 mg) | N/A | |
2934990005 | |||
USP-1235139 | Emtricitabine System Suitability Mixture B (15 mg) | N/A | |
3822190000 | |||
USP-1235240 | Emulsifying Wax (30 mg) | N/A | |
3404200000 | |||
USP-1235274 | Enalaprilat (300 mg) | 84680-54-6 | |
2933995300 | |||
USP-1235300 | Enalapril Maleate (200 mg) | 76095-16-4 | |
2933995300 | |||
USP-1235332 | Enalapril Related Compound D (25 mg) ((S)-Ethyl 2-[(3S,8aS)-3-methyl-1,4-dioxohexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl]-4-phenylbutanoate) | 115729-52-7 | |
2933790002 | |||
USP-1235365 | Enalapril Related Compound H (25 mg) (1-{N-[(S)-1-Ethoxycarbonyl-3-cyclohexylpropyl]-L-alanyl}-L-proline, maleate (1:1)) | n/a | |
2933999552 | |||
USP-1236700 | (-)-Epigallocatechin-3-O-gallate (20 mg) | 989-51-5 | |
2932996560 | |||
USP-1236801 | Epilactose (200 mg) | 50468-56-9 | |
2940006000 | |||
USP-1236833 | Lovastatin Epimer Mixture (25 mg) (Epilovastatin and Lovastatin 1:1 Mixture) | N/A | |
2932206000 | |||
USP-1236889 | Epinastine Hydrochloride (250 mg) | 108929-04-0 | UN2811 |
USP-1236890 | Epinastine Related Compound A (25 mg) ((6,11-Dihydro-5H-dibenzo[b,e]azepin-6-yl)methanamine fumarate) | 127785-96-0 | |
2933992600 | |||
USP-1236970 | Epinephrine (200 mg) | 51-43-4 | UN2811 |
USP-1237000 | Epinephrine Bitartrate (200 mg) | 51-42-3 | UN2811 |
USP-1237382 | Epirubicin Hydrochloride (200 mg) | 56390-09-1 | |
2941906000 | |||
USP-1237553 | Eplerenone (250 mg) | 107724-20-9 | |
2932202000 | |||
USP-1237622 | Epoprostenol Related Compound B (15 mg) (Sodium 5-(diphenylphosphinoyl)pentanoate) | N/A | |
2937500000 | |||
USP-1238002 | Equilin (25 mg) | 474-86-2 | |
2937230000 | |||
USP-1238217 | Eprosartan Mesylate (50 mg) ((E)-2-Butyl-1-(p-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid, monomethanesulfonate) | 144143-96-4 | |
2934990005 | |||
USP-1238228 | Eprosartan Related Compound A (20 mg) ((E)-3-(2-butyl-1H-imidazol-5-yl)-2-(thiophen-2-ylmethyl)acrylic acid hydrochloride) | N/A | |
2934990005 | |||
USP-1238239 | Eprosartan Related Compound B (15 mg) (3-(thiophen-2-yl)propanoic acid) | 5928-51-8 | UN3261 |
USP-1238240 | Eprosartan Related Compound C (25 mg) (2-(thiophen-2-ylmethyl)malonic acid) | 4475-24-5 | |
2934990005 | |||
USP-1238251 | Eprosartan Related Compound D (15 mg) (4-(bromomethyl)benzoic acid) | 6232-88-8 | UN3261 |
USP-1238262 | Eprosartan Related Compound E (15 mg) (4-(hydroxymethyl)benzoic acid) | 3006-96-0 | |
2918992090 | |||
USP-1238512 | Beta-3-Asp Eptifibatide (10 mg) (N6-Amidino-N2-(3-mercaptopropionyl)-L-lysylglycyl-L-Beta-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide, cyclic(1-6)-disulfide) | NA | |
2934990005 | |||
USP-1238523 | D-Har Eptifibatide (10 mg) (N6-Amidino-N2-(3-mercaptopropionyl)-D-lysylglycyl-D-alpha-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide, cyclic(1-6)-disulfide) | NA | |
2934990005 | |||
USP-1238556 | 3-D-Asp Eptifibatide (10 mg) (N6-Amidino-N2-(3-mercaptopropionyl)-L-lysylglycyl-D-alpha-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide, cyclic(1-6)-disulfide) | NA | |
2934990005 | |||
USP-1238578 | 6-D-Cys Eptifibatide (10 mg) (N6-Amidino-N2-(3-mercaptopropionyl)-L-lysylglycyl-L-alpha-aspartyl-L-tryptophyl-L-prolyl-D-cysteinamide, cyclic(1-6)-disulfide) | NA | |
2934990005 | |||
USP-1239504 | Ergoloid Mesylates (300 mg) | 8067-24-1 | |
3003490000 | |||
USP-1241007 | Ergosterol (50 mg) | 57-87-4 | UN2811 |
USP-1241550 | Ergotaminine (100 mg) | 639-81-6 | |
2939690000 | |||
USP-1241608 | Erlotinib Hydrochloride (150 mg) | 183319-69-9 | |
2933595960 | |||
USP-1269232 | Famotidine Related Compound C (25 mg) (3-[[2-(Diaminomethyleneamino)thiazol-4-yl]methylthio]-N-sulfamoylpropanamide hydrochloride) | 76824-17-4 | |
2934100000 | |||
USP-1269243 | Famotidine Related Compound D (25 mg) (3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylthio]propanamide) | 76824-16-3 | |
2934990005 | |||
USP-1349740 | Methoxsalen Related Compound B (25 mg) (4,9-Dimethoxy-7H-furo[3,2-g]chromen-7-one) | 482-27-9 | |
2932202000 | |||
USP-1359415 | Levetiracetam Racemic Mixture (15 mg) (1:1 mixture of levetiracetam S-enantiomer-(2S)-2-(2-oxopyrrolidin-1-yl)butanamide and levetiracetam R-enantiomer (2R)-2-(2-oxopyrrolidin-1-yl)butanamide) | 33996-58-6 | |
2933790002 | |||
USP-1359426 | Levetiracetam Related Compound A (20 mg) ((S)-N-(1-amino-1-oxobutan-2-yl)-4-chlorobutanamide) | 102767-31-7 | |
2924190002 | |||
USP-1359437 | Levetiracetam Related Compound B (20 mg) ((S)-2-aminobutanamide hydrochloride) | 7682-20-4 | |
2924190002 | |||
USP-1359801 | Levobunolol Hydrochloride (200 mg) | 27912-14-7 | |
2922504500 | |||
USP-1359856 | Levocabastine Hydrochloride (50 mg) | 79547-78-7 | |
2933399095 | |||
USP-1359867 | Levocabastine Related Compound A (50 mg) (1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-4-phenylpiperidine-4-carboxylic acid hydrochloride) | 80139-91-9 | |
2933399095 | |||
USP-1359903 | Levocarnitine (400 mg) | 541-15-1 | |
2923900100 | |||
USP-1370360 | Lorazepam Related Compound E (25 mg) (6-Chloro-4-(o-chlorophenyl)-2-quinazoline methanol) | 773871-49-1 | |
2933998350 | |||
USP-1370462 | Losartan Potassium (150 mg) | 124750-99-8 | |
2933290000 | |||
USP-1370473 | Losartan Related Compound A (20 mg) (2-Butyl-4-chloro-1H-imidazole-5-carbaldehyde) | 83857-96-9 | UN3077 |
USP-1370484 | Losartan Related Compound B (20 mg) (2-Butyl-4-chloro-(1-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methyl acetate) | 1006062-27-6 | |
2933290000 | |||
USP-1370495 | Losartan Related Compound C (20 mg) (2-Butyl-4-chloro-1-[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazol-5-carbaldehyde) | 114798-36-6 | |
2933290000 | |||
USP-1370509 | Losartan Related Compound D (20 mg) (5-[4′-({2-Butyl-5-[(5-{4′-[(2-butyl-4-chloro-5-hydroxymethyl-1H-imidazol-1-yl)methyl]biphenyl-2-yl}-1H-tetrazol-1-yl)methyl]-4-chloro-1H-imidazol-1-yl}methyl)biphenyl-2-yl]tetrazol, potassium salt) | N/A | |
2933290000 | |||
USP-1370510 | Losartan Related Compound E (20 mg) (5-[4′-({2-Butyl-5-[(5-{4′-[(2-butyl-4-chloro-5-hydroxymethyl-1H-imidazol-1-yl)methyl]biphenyl-2-yl}-2H-tetrazol-2-yl)methyl]-4-chloro-1H-imidazol-1-yl}methyl)biphenyl-2-yl]tetrazol, potassium salt) | N/A | |
2933290000 | |||
USP-1370600 | Lovastatin (125 mg) | 75330-75-5 | |
2932206000 | |||
USP-1370611 | Lovastatin Related Compound A (20 mg) (4,4a-Dihydrolovastatin) | N/A | |
2933997500 | |||
USP-1370655 | Lovastatin Impurity Identification Mixture (30 mg) | N/A | |
3822190000 | |||
USP-1370688 | Low-substituted Carboxymethylcellulose Sodium (100 mg) | 9004-32-4 | |
3912310000 | |||
USP-1370699 | Loxapine N-Oxide (25 mg) (4-(2-Chlorodibenzo[b,f][1,4]oxazepin-11-yl)-1-methylpiperazine 1-oxide) | 25967-34-4 | |
2934990005 | |||
USP-1370702 | Loxapine Succinate (125 mg) | 27833-64-3 | UN2811 |
USP-1370713 | Loxapine Related Compound A (20 mg) (3-Chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepine) | 3454-96-4 | |
2934990005 | |||
USP-1370724 | Lufenuron Related Compound B (15 mg) (N-[(2,5-Dichloro-4-hydroxyphenyl)carbamoyl]-2,6-difluorobenzamide) | N/A | |
2924210000 | |||
USP-1370735 | Lufenuron Related Compound C (15 mg) (N-[3-Chloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenylcarbamoyl]-2,6-difluorobenzamide) | N/A | |
2924210000 | |||
USP-1370746 | Lumefantrine (100 mg) | 82186-77-4 | |
2922190900 | |||
USP-1370757 | Lumefantrine Related Compound A (25 mg) ((RS, Z)-2-(Dibutylamino)-2-(2,7-dichloro-9-(4-chlorobenzylidene)-9H-fluoren-4-yl)ethanol hydrochloride) | NA | |
2922199695 | |||
USP-1437020 | Methylprednisolone Hemisuccinate Related Compound B (50 mg) (11Beta,21-Dihydroxy-6alpha-methyl-3,20-dioxopregna-1,4-dien-17-yl hydrogen succinate) | 77074-42-1 | |
2918992090 | |||
USP-1437042 | Methylprednisolone Hemisuccinate Related Compound D (50 mg) (11Beta,17-Dihydroxy-6alpha-methyl-3,20-dioxopregna-4-en-21-yl hydrogen succinate) | 119657-85-1 | |
2937290000 | |||
USP-1437461 | Methyl Salicylate Related Compound A (50 mg) (Dimethyl 4-hydroxyisophthalate) | 5985-24-0 | |
2918230000 | |||
USP-1437508 | Methyl Stearate (300 mg) | 112-61-8 | |
2915700100 | |||
USP-1437600 | Methylsulfonylmethane (200 mg) | 67-71-0 | |
2930909265 | |||
USP-1437701 | Terbinafine Related Compound D (25 mg) ((2E)-N,6,6-trimethyl-N-[(4-methylnaphthalen-1-yl)methyl]-hept-2-en-4-yn-1-amine hydrochloride) | 877265-33-3 | |
2921490002 | |||
USP-1438205 | Methyl Tricosanoate (200 mg) (Tricosanoic acid, methyl ester) | 2433-97-8 | |
2915900000 | |||
USP-1438318 | 5-O-Methylvisammioside (25 mg) | 84272-85-5 | |
2938900000 | |||
USP-1448967 | Mycophenolate Mofetil Related Compound A (15 mg) (2-Morpholinoethyl (E)-6-(1,3-dihydro-4,6-dihydroxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate) | 1322681-36-6 | |
2934990005 | |||
USP-1448978 | Mycophenolate Mofetil Related Compound B (15 mg) [(RS)-7-hydroxy-5-methoxy-4-methyl-6-[2-(5-methyl-2-oxo-tetrahydrofuran-5-yl)ethyl]-3H-isobenzofuranyl-1-one] | 26675-76-3 | |
2932206000 | |||
USP-1448989 | Mycophenolate Sodium (200 mg) | 37415-62-6 | UN3077 |
USP-1448990 | Myristic Acid (200 mg) | 544-63-8 | |
2915900000 | |||
USP-1449008 | Myristyl Alcohol (5 x 100 mg) | 112-72-1 | |
2905199095 | |||
USP-1449041 | Myristylpyridinium Chloride (25 mg) (1-Tetradecylpyridinium chloride) | 2785-54-8 | UN2811 |
USP-1449518 | Nabumetone (200 mg) | 42924-53-8 | |
2914500000 | |||
USP-1449530 | Nabumetone Related Compound A (15 mg) (1-(6-methoxy-2-naphthyl)-but-1-en-3-one) | 127053-22-9 | |
2914500000 | |||
USP-1449700 | Nadolol (200 mg) | 42200-33-9 | |
2922190900 | |||
USP-1449711 | Nadolol Related Compound A (25 mg) ((2RS,3SR)-5-(2,3-Dihydroxypropoxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol) | N/A | |
2909500000 | |||
USP-1449722 | Nadolol Related Compound B (25 mg) ((2RS,3SR)-5-(2-Hydroxy-3-methoxypropoxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol) | N/A | |
2909490000 | |||
USP-1449733 | Nadolol Related Compound C (25 mg) | N/A | |
2909490000 | |||
USP-1449766 | Nadolol Related Compound F (25 mg) (1-(tert-Butylamino)-3-(naphthalen-1-yloxy)propan-2-ol) | 2116-22-5 | |
2922199695 | |||
USP-1449777 | Nadolol Related Compound G (25 mg) (1-(tert-Butylamino)-3-(5,6,7,8-tetrahydronaphthalen-1-yloxy)propan-2-ol) | 33841-03-1 | |
2922199695 | |||
USP-1450007 | Nafcillin Sodium (200 mg) | 7177-50-6 | |
2941106000 | |||
USP-1605500 | Ropivacaine Hydrochloride (200 mg) | 132112-35-7 | |
2933399095 | |||
USP-1605512 | Ropivacaine Related Compound A (25 mg) (2,6-dimethylaniline hydrochloride) | 21436-98-6 | |
2921490002 | |||
USP-1605523 | Ropivacaine Related Compound B (50 mg) ((R)-N-(2,6-Dimethylphenyl)-1-propylpiperidine-2-carboxamide hydrochloride monohydrate) | N/A | |
2933399095 | |||
USP-1605588 | Rosavin (25 mg) ((2E)-3-Phenylprop-2-en-1-yl 6-O-alpha-l-arabinopyranosyl-Beta-D-glucopyranoside) | 84954-92-7 | |
2939790000 | |||
USP-1605668 | Powdered Rosemary Extract (1 g) | 84604-14-8 | |
1302190200 | |||
USP-1605680 | Powdered Rosemary Hydrophilic Extract (1 g) | 84604-14-8 | |
1302190200 | |||
USP-1605817 | Rosiglitazone Maleate (200 mg) | 122320-73-4 | |
2934100000 | |||
USP-1605828 | Rosiglitazone Related Compound A (25 mg) ((5Z)-5-{[4-({2-[methyl(2-pyridinyl)amino]ethyl}oxy)phenyl]methylidene}-1,3-thiazolidine-2,4-dione) | 160596-25-8 | |
2934100000 | |||
USP-1605952 | Rosmarinic Acid (25 mg) | 20283-92-5 | |
2918992090 | |||
USP-1606004 | Rosuvastatin System Suitability Mixture (15 mg) (A mixture containing rosuvastatin calcium, rosuvastatin ketone, rosuvastatin lactone and rosuvastatin diastereomers.) | N/A | |
3822190000 |
标签归档:USP标准物质代理
美国药典USP标准品CAS编号查询(三十四),USP标准物质代理
USP订购编号 | 美国药典,USP分析标准品,英文名称,规格 | CAS编号查询 | UN编号对照 |
USP-1269254 | Famotidine Related Compound E (25 mg) (2,2′-[4,4′-disulfanediylbis(methylene)bis(thiazole-4,2-diyl)]diguanidine) | 129083-44-9 | |
2934100000 | |||
USP-1269265 | Famotidine Related Compound F (25 mg) (3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylthio]propanoic acid) | 107880-74-0 | |
2934100000 | |||
USP-1269312 | Felbamate (250 mg) | 25451-15-4 | |
2924296000 | |||
USP-1269323 | Felbamate Related Compound A (25 mg) (3-Hydroxy-2-phenylpropyl carbamate) | 25451-53-0 | |
2924296000 | |||
USP-1269334 | Felbamate Related Compound B (25 mg) (Phenethyl carbamate) | 6326-19-8 | |
2924296000 | |||
USP-1269356 | Febantel (200 mg) | 58306-30-2 | UN3077 |
USP-1269367 | Febantel Related Compound A (15 mg) (Methyl [[2-[(methoxyacetyl)amino]-4-(phenylthio)phenyl]carbamimidoyl]carbamate) | 92088-58-9 | |
2930902000 | |||
USP-1283368 | Fosamprenavir Calcium (200 mg) | 226700-81-8 | |
2935904000 | |||
USP-1283379 | Fosamprenavir Related Compound A (10 mg) | N/A | |
2930902000 | |||
USP-1283380 | Fosamprenavir System Suitability Mixture (15 mg) (A mixture of fosamprenavir calcium, fosamprenavir pyrophosphate, fosamprenavir n-propyl homolog and fosamprenavir n-butyl isomer. Other impurities may also be present) | N/A | |
3822190000 | |||
USP-1283404 | Fosinopril Sodium (200 mg) | 88889-14-9 | |
2933995300 | |||
USP-1285931 | Fluvastatin Sodium (2 x 350 mg) | 93957-55-2 | |
2933995300 | |||
USP-1285942 | Fluvastatin for System Suitability (25 mg) (Fluvastatin sodium and fluvastatin sodium anti-isomer ([R*,R*-E]-(+/-)-7-[3-(4-Fluorophenyl)-1-(methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid monosodium salt)) | N/A | |
3822190000 | |||
USP-1297250 | Goserelin System Suitability Mixture (1.075 mg) (需冷链运输) | N/A | |
3822190000 | |||
USP-1297770 | Powdered Centella Asiatica Extract (1 g) | N/A | |
1302190200 | |||
USP-1298004 | Gramicidin (200 mg) | 1405-97-6 | |
2941906000 | |||
USP-1298092 | Granisetron (100 mg) | 109889-09-0 | |
2933399095 | |||
USP-1298106 | Granisetron Hydrochloride (150 mg) | 107007-99-8 | |
2933399095 | |||
USP-1349149 | Isoguaifenesin (30 mg) | 14007-09-1 | |
2909490000 | |||
USP-1349502 | L-Isoleucine (200 mg) | 73-32-5 | |
2922498050 | |||
USP-1349626 | Isomalt (200 mg) | 64519-82-0 | |
2940006000 | |||
USP-1349659 | Isometheptene Mucate (200 mg) | 7492-31-1 | |
2921196190 | |||
USP-1349670 | Isonaringin (30 mg) ((RS)-5-Hydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranoside) | 14259-46-2 | |
2938100000 | |||
USP-1349706 | Isoniazid (200 mg) | 54-85-3 | |
2933399095 | |||
USP-1148500 | Copovidone (100 mg) | 25086-89-9 | |
3905915000 | |||
USP-1148555 | Coptis Chinensis Rhizome Dry Extract (150 mg) | N/A | |
1302190200 | |||
USP-1148566 | Coptisine Chloride (15 mg) | 6020-18-4 | |
2939790000 | |||
USP-1148737 | Corosolic Acid (50 mg) | 4547-24-4 | |
2918195000 | |||
USP-1149999 | Cortisone (20 mg) (17, 21-Dihydroxypregna-4-ene-3,11,20-trione) | 1953/6/5 | |
2937210000 | |||
USP-1150003 | Cortisone Acetate (150 mg) | 1950/4/4 | |
2937290000 | |||
USP-1150218 | Cranberry Fruit Juice Dry Extract (200 mg) | N/A | |
1302190200 | |||
USP-1150320 | Creatine (200 mg) | 6020-87-7 | |
2925299000 | |||
USP-1150353 | Creatinine (100 mg) (2-Imino-1-methylimidazolidin-4-one) | 60-27-5 | |
2933290000 | |||
USP-1150502 | Cromolyn Sodium (500 mg) | 15826-37-6 | |
2932996560 | |||
USP-1150513 | Cromolyn Related Compound A (25 mg) (1,3-bis(2-acetyl-3-hydroxyphenoxy) propan-2-ol) | 16150-44-0 | |
2914500000 | |||
USP-1150524 | Cromolyn Related Compound B (25 mg) (diethyl 5,5′-[(2-hydroxypropane-1,3-diyl)bis(oxy)]bis(4-oxo-4H-chromene-2-carboxylate)) | N/A | |
2932996560 | |||
USP-1150659 | Croscarmellose Sodium (20 mg) | 74811-65-7 | |
3912310000 | |||
USP-1150706 | Crospovidone (100 mg) | 9003-39-8 | |
3905998000 | |||
USP-1151006 | Crotamiton (200 mg) | 483-63-6 | |
2924296000 | |||
USP-1606015 | Rosuvastatin Calcium (300 mg) | 147098-20-2 | |
2935904000 | |||
USP-1606026 | Rosuvastatin Related Compound A (25 mg) (Calcium (3R,5S,E)-7-{4-(4-fluorophenyl)-2-[(2-hydroxy-N,2-dimethylpropyl)sulfonamide]-6-isopropylpyrimidin-5-yl}-3,5-dihydroxyhept-6-enoate salt (1:2)) | 1714147-47-3 | |
2935909550 | |||
USP-1606037 | Rosuvastatin Related Compound B (25 mg) | N/A | |
2935909550 | |||
USP-1606048 | Rosuvastatin Related Compound C (25 mg) (tert-Butyl2-[(4R,6S)-6-{(E)-2-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl]vinyl}-2,2-dimethyl-1,3-dioxan-4-yl]acetate) | 289042-12-2 | |
2935909550 | |||
USP-1606059 | Rosuvastatin Enantiomer (25 mg) (Calcium (3S,5R,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate salt (1:2)) | N/A | |
2935909550 | |||
USP-1614669 | Sodium Starch Glycolate Type A (400 mg) | 9063-38-1 | |
3505100092 | |||
USP-1614670 | Sodium Starch Glycolate Type B (400 mg) | 9063-38-1 | |
3505100092 | |||
USP-1614705 | Sodium Stearyl Fumarate (200 mg) | 4070-80-8 | |
2917191600 | |||
USP-1614716 | Anhydrous Sodium Succinate (250 mg) | 150-90-3 | |
2917197055 | |||
USP-1614807 | Sodium Sulfate Anhydrous (1 g) | 7757-82-6 | |
2833115000 | |||
USP-1134335 | Ciprofloxacin Hydrochloride (400 mg) | 86393-32-0 | |
2933595960 | |||
USP-1140597 | Clopidogrel Related Compound B (20 mg) (Methyl(+/-)-(o-chlorophenyl)-4,5-dihydrothieno[2,3-c]pyridine-6(7H)-acetate, hydrochloride) | 144750-52-7 | |
2934990005 | |||
USP-1140600 | Clopidogrel Related Compound C (20 mg) (methyl (-)-(R)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate, hydrogen sulfate) | 120202-71-3 | UN3261 |
USP-1140666 | Cloprostenol Sodium (400 mg) | 55028-72-3 | |
2937500000 | |||
USP-1140702 | Clorsulon (200 mg) | 60200-06-8 | |
2935904000 | |||
USP-1141002 | Clotrimazole (200 mg) | 23593-75-1 | |
2933290000 | |||
USP-1141024 | Clotrimazole Related Compound A (25 mg) ((o-chlorophenyl)diphenylmethanol) | 66774-02-5 | |
2906290000 | |||
USP-1141909 | Cloxacillin Benzathine (200 mg) | 23736-58-5 | |
2941106000 | |||
USP-1142005 | Cloxacillin Sodium (200 mg) | 7081-44-9 | |
2941106000 | |||
USP-1142107 | Clozapine (100 mg) | 5786-21-0 | UN2811 |
USP-1142108 | Clozapine Resolution Mixture (30 mg) | N/A | UN2811 |
USP-1144951 | Cloxacillin Related Compound D (15 mg) (3-(2-Chlorophenyl)-5-methylisoxazole-4-carboxylic acid) | 23598-72-3 | |
2934990005 | |||
USP-1145411 | Coffee Fruit Dry Extract (1 g) | N/A | |
2101112949 | |||
USP-1146006 | Colchicine (350 mg) | 64-86-8 | UN1544 |
USP-1146505 | Colestipol Hydrochloride (200 mg) | 37296-80-3 | |
3914006000 | |||
USP-1147009 | Colistimethate Sodium (200 mg) | 8068-28-8 | |
2941906000 | |||
USP-1148001 | Colistin Sulfate (200 mg) | 1264-72-8 | UN2811 |
USP-1148238 | Color Related Compound 005 (20 mg) (3-hydroxy-2-naphthalenecarboxylic acid) | 92-70-6 | |
2918290000 | |||
USP-1148249 | Color Related Compound 006 (20 mg) (3-hydroxy-4-[(4-methylphenyl)azo]-2-naphthalenecarboxylic acid) | 82896-77-3 | |
2927000000 | |||
USP-1148250 | Color Related Compound 007 (20 mg) (1-[(4-methylphenyl)azo]-2-naphthalenol) | 6756-41-8 | |
2927000000 | |||
USP-1151651 | Cullen Corylifolium Fruit Dry Extract (1 g) | N/A | |
1302190200 | |||
USP-1151855 | Curcumin (30 mg) | 458-37-7 | |
3203000000 | |||
USP-1151866 | Curcuminoids (300 mg) | N/A | |
3822190000 | |||
USP-1151924 | Cyanidin Chloride (25 mg) | 528-58-5 | |
2932996560 | |||
USP-1152011 | Cyanocobalamin (Crystalline) (2 x 150 mg) | 68-19-9 | |
2936260000 | |||
USP-1065287 | Bendamustine Related Compound F (20 mg) (Mannitol-1-yl 4-{5-[bis(2-chloroethyl)amino]-1-methyl-1H -benzimidazol-2-yl}butanoate) | 1869075-89-7 | |
2933998350 | |||
USP-1065298 | Bendamustine Related Compound G (20 mg) (4-[6-(2-Chloroethyl)-3,6,7,8-tetrahydro-3-methylimidazo[4,5-h][1,4]benzothiazin-2-yl]butanoic acid hydrochloride) | N/A | |
2934990005 | |||
USP-1065301 | Bendamustine Related Compound H (25 mg) (4-[5-({2-[(4-{5-[Bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoyl)oxy]ethyl}(2-chloroethyl)amino)-1-methyl-1H-benzimidazol-2-yl]butanoic acid) | 1228551-91-4 | |
2933998350 | |||
USP-1065312 | Bendamustine Related Compound I (25 mg) (Ethyl 4-{5-[bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoate) | 87475-54-5 | |
2933998350 | |||
USP-1065345 | Methoxsalen Related Compound A (25 mg) (4-Methoxy-7H-furo[3,2-g]chromen-7-one) | 484-20-8 | |
2932206000 | |||
USP-1065550 | Betadex Sulfobutyl Ether Sodium (500 mg) | 182410-00-0 | |
2940006000 | |||
USP-1065618 | Betahistine Hydrochloride (200 mg) | 5579-84-0 | |
2933399095 | |||
USP-1065695 | Betaine (1 g) | 107-43-7 | |
2923900100 | |||
USP-1065709 | Betaine Hydrochloride (200 mg) | 590-46-5 | |
2923900100 | |||
USP-1066009 | Betamethasone (200 mg) | 378-44-9 | UN2811 |
USP-1076148 | Bosentan Related Compound C (15 mg) (1,2-bis({6-[4-(tert-butyl)phenylsulfonamido]-5-(2-methoxyphenoxy)-[2,2′-bipyrimidin]-4-yl}oxy)ethane) | 1097263-60-9 | |
2935909550 | |||
USP-1096531 | Carboxymethylcellulose Calcium (1.5 g) (AS) | 9050/4/8 | |
3912310000 | |||
USP-1096553 | Carboxymethylcellulose Sodium (1.5 g) | 9004-32-4 | |
3912310000 | |||
USP-1096564 | D-Carglumic Acid (30 mg) (N-Carbamoyl-D-glutamic acid) | 26117-15-7 | |
2924190002 |
美国药典USP标准品CAS编号查询(三十三),USP标准物质代理
USP订购编号 | 美国药典,USP分析标准品,英文名称,规格 | CAS编号查询 | UN编号对照 |
USP-1285964 | Fluvastatin Related Compound B (15 mg) ([R*,S*-E]-(+/-)-7-[3-(4-fluorophenyl)-1-methylethyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid 1,1, dimethylethyl ester) | 129332-29-2 | |
2933997500 | |||
USP-1285986 | Flutamide Related Compound B (20 mg) (N-[4-nitro-3-(trifluoromethyl)phenyl]acetamide) | 393-12-4 | UN3261 |
USP-1285997 | Flutamide Related Compound A (20 mg) (4-nitro-3-(trifluoromethyl)aniline) | 393-11-3 | |
2924296000 | |||
USP-1286005 | Folic Acid (500 mg) (Vitamin M or Vitamin Bc) | 59-30-3 | |
2936291000 | |||
USP-1286027 | Folic Acid Related Compound A (50 mg) (Calcium Formyltetrahydrofolate) | 1492-18-8 | |
2936299055 | |||
USP-1286060 | Formononetin (50 mg) | 485-72-3 | |
2932996560 | |||
USP-1286107 | Formoterol Fumarate (200 mg) | 183814-30-4 | UN2811 |
USP-1286141 | Formoterol Related Compound D (30 mg) (N-(2-Hydroxy-5-(1-hydroxy-2-{[1-(4-methoxyphenyl)propan-2-yl](methyl)amino}ethyl)phenyl)formamide fumarate) | 1795133-97-9 | |
2924296000 | |||
USP-1286184 | Formoterol Related Compound I (25 mg) (N-(2-hydroxy-5-[(RS)-1-hydroxy-2-{[(SR)-1-(4-methoxyphenyl)propan-2-yl]amino}ethyl]phenyl)formamide) | 532414-36-1 | |
2924296000 | |||
USP-1286209 | Mafenide Related Compound A (50 mg) (4-Formylbenzenesulfonamide) | 3240-35-5 | |
2935909550 | |||
USP-1286300 | 10-Formylfolic Acid (25 mg) (L-Glutamic acid, N-[4-[[(2-amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl]formylamino-]benzoyl]-) | 134-05-4 | |
2936299055 | |||
USP-1286311 | Formyl Penicillamine (25 mg) (2-Formamido-3-mercapto-3-methylbutanoic acid) | 158411-82-6 | |
2930909265 | |||
USP-1286322 | Fosfomycin Tromethamine (800 mg) | 78964-85-9 | |
2941906000 | |||
USP-1286366 | Fosphenytoin Sodium (350 mg) | 2214317-48-1 | |
2933290000 | |||
USP-1286402 | Frovatriptan Racemate (15 mg) | 147009-08-3 | |
2933995500 | |||
USP-1296010 | Glycopyrrolate Erythro Isomer (25 mg) ((RS)-3-[(RS)-2-cyclopentyl-2-hydroxy-2-phenylacetoxy]-1,1-dimethylpyrrolidinium bromide) | N/A | |
2933998350 | |||
USP-1296029 | Glycopyrrolate Related Compound A (50 mg) (5-Nitrobenzene-1,3-dicarboxylic acid) | 618-88-2 | |
2917394000 | |||
USP-1296031 | Glycopyrrolate Related Compound B (50 mg) (1-Methylpyrrolidin-3-yl 2-cyclopentyl-2-hydroxy-2-phenylacetate Hydrochloride) | 13118-10-0 | |
2917394000 | |||
USP-1296042 | Glycopyrrolate Related Compound C (25 mg) (2-Cyclopentyl-2-hydroxy-2-phenylacetic acid) | 427-49-6 | |
2918195000 | |||
USP-1296086 | Glycopyrrolate Related Compound I (15 mg) ((RS)-3-[(SR)-2-(4-Chlorophenyl)-2-cyclopentyl-2-hydroxyacetoxy]-1,1-dimethylpyrrolidin-1-ium bromide) | N/A | |
2933998350 | |||
USP-1296701 | [D-His2]-Gonadorelin (1 mg) (5-Oxo-L-prolyl-D-histidyl-L-tryptophyl-L-seryl-L-tyrosylglycyl-L-leucyl-L-arginyl-L-prolylglycinamide) | 53634-19-8 | |
2933998350 | |||
USP-1296712 | [D-Tyr5]-Gonadorelin (1 mg) (5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-D-tyrosylglycyl-L-leucyl-L-arginyl-L-prolylglycinamide) | 53634-21-2 | |
2933998350 | |||
USP-1297205 | Goserelin Acetate (100 mg) (需冷链运输) | 145781-92-6 | |
2937190000 | |||
USP-1297216 | Goserelin Related Compound A (10 mg) (4-D-Serine Goserelin, 1-(5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-D-seryl-L-tyrosyl-O-tert-butyl-D-seryl-L-leucyl-L-arginyl-L-prolyl) semicarbazide) (需冷链运输) | 1926163-39-4 | |
2933790002 | |||
USP-1096586 | Carglumic Acid (200 mg) | 1188-38-1 | |
2924190002 | |||
USP-1096597 | Carisoprodol Related Compound A (10 mg) (2-hydroxymethyl-2-methylpentyl carbamate) | 1471-56-3 | |
2924190002 | |||
USP-1096611 | Carmellose (500 mg) | 9000/11/7 | |
3912310000 | |||
USP-1096622 | Carvedilol (200 mg) | 72956-09-3 | UN3077 |
USP-1096633 | Carvedilol Related Compound A (15 mg) (1-(4-(2-hydroxy-3-(2-(2-methoxyphenoxy)ethylamino)propoxy)-9H-carbazol-9-yl)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol) | 1198090-73-1 | |
2933997500 | |||
USP-1096644 | Carvedilol Related Compound B (15 mg) (3,3′-(2-(2-methoxyphenoxy)ethylazanediyl)bis(1-(9H-carbazol-4-yloxy)propan-2-ol)) | 918903-20-5 | |
2933998350 | |||
USP-1096655 | Carvedilol Related Compound C (20 mg) (1-(9H-Carbazol-4-yloxy)-3-(benzyl(2-(2-methoxyphenoxy)ethyl)amino)propan-2-ol) | 72955-94-3 | |
2933997500 | |||
USP-1096666 | Carvedilol Related Compound D (15 mg) (4-(Oxiran-2-ylmethoxy)-9H-carbazole) | 51997-51-4 | |
2933997500 | |||
USP-1096677 | Carvedilol Related Compound E (15 mg) (2-(2-Methoxyphenoxy)ethyl amine hydrochloride monohydrate) | 2057412-43-6 | |
2922504500 | |||
USP-1096688 | Carvedilol System Suitability Mixture (25 mg) (carvedilol spiked with carvedilol related compound F) | N/A | UN3077 |
USP-1096699 | Carprofen (200 mg) | 53716-49-7 | UN2811 |
USP-1096724 | Carmustine (75 mg) (需冷链运输) | 154-93-8 | UN2811 |
USP-1096735 | Carmustine Related Compound A (25 mg) (1,3-bis(2-chloroethyl)urea) | 2214-72-4 | |
2924190002 | |||
USP-1096746 | Carnosic acid (20 mg) | 3650/9/7 | |
2918195000 | |||
USP-1096757 | Carteolol Hydrochloride (200 mg) | 51781-21-6 | |
2933790002 | |||
USP-1134084 | Ciclopirox Related Compound C (10 mg) (6-Cyclohexyl-4-methylpyridin-2(1H)-one) | 67587-24-0 | |
2934990005 | |||
USP-1134120 | Cisapride (200 mg) | 260779-88-2 | |
2933399095 | |||
USP-1134131 | Cisatracurium Besylate System Suitability Mixture (20 mg) | N/A | UN2811 |
USP-1134142 | R-Citalopram Oxalate (10 mg) ((R)-1-[3-(Dimethylamino)propyl]-1-(p-fluorophenyl)-5-phthalancarbonitrile oxalate) | 219861-53-7 | |
2932996560 | |||
USP-1134153 | Cilostazol (200 mg) | 73963-72-1 | |
2933790002 | |||
USP-1134164 | Cilostazol Related Compound A (50 mg) (6-hydroxy-3,4-dihydro-1H-quinolin-2-one) | 54197-66-9 | |
2933790002 | |||
USP-1134175 | Cilostazol Related Compound B (50 mg) (6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-1H-quinolin-2-one) | 73963-62-9 | |
2933790002 | |||
USP-1134186 | Cilostazol Related Compound C (50 mg) (1-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one) | 865792-18-3 | |
2933790002 | |||
USP-1134197 | Citalopram Related Compound G (25 mg) (1-(4′-fluorophenyl)-1-(3-dimethylaminopropyl)-5-chlorophthalane hydrobromide) | N/A | |
2932996560 | |||
USP-1134200 | Cladribine (200 mg) | 4291-63-8 | |
2934990005 | |||
USP-1134211 | Cladribine Related Compound A (20 mg) (2-methoxy-2′-deoxyadenosine) | 24757-70-8 | |
2934990005 | |||
USP-1134222 | Citalopram Related Compound H (25 mg) (1-(4′-fluorophenyl)-1-(3-dimethylaminopropyl)-5-bromophthalane hydrobromide) | 479065-02-6 | |
2932996560 | |||
USP-1134233 | Citalopram Hydrobromide (200 mg) | 59729-32-7 | UN3077 |
USP-1134244 | Citalopram Related Compound A (25 mg) (1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carboxamide) | 64372-56-1 | |
2932996560 | |||
USP-1134255 | Citalopram Related Compound B (25 mg) (1-(3-Dimethylaminopropyl)-1-(4-fluorophenyl)-3-hydroxy-1,3-dihydroisobenzofuran-5-carbonitrile oxalate) | 1332724-03-4 | |
2932996560 | |||
USP-1134266 | Citalopram Related Compound C (25 mg) (3-(3-Dimethylaminopropyl)-3-(4-fluorophenyl)-6-cyano-1(3H)-isobenzofuranone oxalate) | 1440961-11-4 | |
2932206000 | |||
USP-1134277 | Citalopram Related Compound D (15 mg) (1-(4-Fluorophenyl)-1-(3-methylaminopropyl)-1,3-dihydroisobenzofuran-5-carbonitrile hydrochloride) | 97743-99-2 | |
2932996560 | |||
USP-1370779 | Lufenuron (200 mg) | 103055-07-8 | UN3077 |
USP-1370780 | Lufenuron Related Compound G (15 mg) (2,5-Dichloro-4-[3-(2,6-difluorobenzoyl)ureido]phenyl phenyl carbonate) | N/A | UN3077 |
USP-1370837 | Luteolin 7-O-Glucoside (30 mg) (2-(3,4-Dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-yl beta-D-glucopyranoside) | 5373/11/5 | |
2938900000 | |||
USP-1370881 | Lycopene Preparation (500 mg) | 502-65-8 | |
3203000000 | |||
USP-1370906 | Lynestrenol (20 mg) ((17alpha) -19-Norpregn-4-en-20-yn-17-ol) | 52-76-6 | |
2937230000 | |||
USP-1371501 | L-Lysine Acetate (200 mg) | 57282-49-2 | |
2922410000 | |||
USP-1372005 | L-Lysine Hydrochloride (200 mg) | 657-27-2 | |
2922410000 | |||
USP-1372344 | Polyamide 6 (1 g) | 25038-54-4 | |
3908100000 | |||
USP-1372435 | Polyoxyl 9 Lauryl Ether (1 g) (Polyethylene glycol monolauryl ether (n=9)) | 9002-92-0 | UN3082 |
USP-1372468 | Polyoxyl 23 Lauryl Ether (0.5 g) | 9002-92-0 | UN3082 |
USP-1372606 | Polyoxyl 10 Stearyl Ether (1 g) | 9005-00-9 | |
3907290000 | |||
USP-1373008 | Mafenide Acetate (200 mg) | 13009-99-9 | |
2935904000 | |||
USP-1380579 | Memantine Related Compound G (30 mg) (3-Methyladamantan-1-amine hydrochloride) | 33103-93-4 | |
2921300000 | |||
USP-1380580 | Memantine Related Compound H (30 mg) (3,5,7-Trimethyladamantan-1-amine hydrochloride) | 15210-60-3 | |
2921300000 | |||
USP-1380591 | Memantine Related Compound I (30 mg) (3-Ethyladamantan-1-amine hydrochloride) | 80121-67-1 | |
2921300000 | |||
USP-1381006 | Menadione (200 mg) | 58-27-5 | UN3077 |
USP-1381083 | Menaquinone-4 (50 mg) (2-Methyl-3-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]naphthalene-1,4-dione) (需冷链运输) | 863-61-6 | |
2914699000 | |||
USP-1381709 | Menthol (250 mg) | 2216-51-5 | |
2906110000 | |||
USP-1387002 | Mepivacaine Hydrochloride (200 mg) | 1722-62-9 | UN2811 |
USP-1391000 | 3-Mercapto-2-methylpropanoic Acid 1,2-Diphenylethylamine Salt (75 mg) | N/A | |
2921490002 | |||
USP-1392002 | Mercaptopurine (500 mg) | 6112-76-1 | |
2933595960 | |||
USP-1392454 | Meropenem (300 mg) | 119478-56-7 | |
2941906000 | |||
USP-1392705 | Mesalamine (200 mg) | 89-57-6 | |
2922504500 | |||
USP-1392807 | Mesna (200 mg) | 19767-45-4 | |
2930909265 | |||
USP-1392818 | Mesna Related Compound A (50 mg) (2-(Acetylthio)ethane-1-sulfonic acid, potassium salt, crystal adduct with potassium chloride) | N/A | |
2930909265 | |||
USP-1392829 | Mesna Related Compound B (50 mg) (2,2′-Disulfanediylbis(ethane-1-sulfonic acid), dipotassium salt, crystal adduct with sodium chloride) | N/A | |
2930909265 | |||
USP-1393005 | Mesoridazine Besylate (25 mg) | 32672-69-8 | |
2934302300 | |||
USP-1394008 | Mestranol (200 mg) | 72-33-3 | |
2937230000 | |||
USP-1606060 | Rotigotine (50 mg) ((S)-6-{Propyl[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol) | 99755-59-6 | UN3077 |
USP-1606079 | Rotigotine Hydrochloride (300 mg) ((6S )-6-[Propyl(2-(2-thienyl)ethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride) | 125572-93-2 | UN3077 |
USP-1606081 | Rotigotine Racemate (25 mg) ((RS)-6-{Propyl[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride) | 102120-99-0 | UN3077 |
USP-1614578 | Sodium Picosulfate (50 mg) | 10040-45-6 | |
2933399095 | |||
USP-1614603 | Sodium Propionate (200 mg) | 137-40-6 | |
2915503000 | |||
USP-1614636 | Sodium Salicylate (500 mg) | 54-21-7 | |
2918211000 |
美国药典USP标准品CAS编号查询(三十二),USP标准物质代理
USP订购编号 | 美国药典,USP分析标准品,英文名称,规格 | CAS编号查询 | UN编号对照 |
USP-1013556 | Almotriptan Related Compound C (15 mg) (N-methyl-2-{5-[(pyrrolidin-1-ylsulfonyl)methyl]-1H-indol-3-yl}ethanamine) | 334981-12-3 | |
2933997500 | |||
USP-1013567 | Almotriptan Related Compound D (15 mg) (1-[({3-[2-(dimethylamino)ethyl]indol-5-yl}methyl)sulfonyl]pyrrolidine N-oxide hydrochloride) | N/A | |
2933997500 | |||
USP-1013727 | Aloin (25 mg) (Aloin A; (S)-10-Beta-D-Glucopyranosyl-1,8-dihydroxy-3-hydroxymethylanthracen-9(10H)-one) | 1415-73-2 | |
2938900000 | |||
USP-1013807 | Alosetron Hydrochloride (200 mg) (2,3,4,5-Tetrahydro-5-methyl-2-[(5-methylimidazol-4-yl)methyl]-1H-pyrido[4,3-b]indol-1-one hydrochloride) | 122852-69-1 | UN2811 |
USP-1013818 | Alosetron Related Compound A (25 mg) (5-Methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one) | 122852-75-9 | |
2933790002 | |||
USP-1015019 | Alprazolam Related Compound A (30 mg) (2-(2-acetylhydrazino)-7-chloro-5-phenyl-3H-1,4-benzodiazepine) | 28910-89-6 | |
2933997500 | |||
USP-1016000 | Alprostadil (25 mg) | 745-65-3 | UN2811 |
USP-1017105 | Altretamine (500 mg) | 645-05-6 | |
2933690000 | |||
USP-1042351 | Formoterol Related Compound A (30 mg) (2-Amino-4-(1-hydroxy-2-((1-(4-methoxyphenyl)propan-2-yl)amino)ethyl)phenol) | 150513-24-9 | |
2922504500 | |||
USP-1042373 | Formoterol Related Compound C (30 mg) (N-(2-Hydroxy-5-(1-hydroxy-2-{[1-(4-methoxyphenyl)propan-2-yl]amino}ethyl)phenyl)acetamide fumarate) | N/A | |
2924296000 | |||
USP-1042408 | Argatroban (350 mg) | 141396-28-3 | |
2935904000 | |||
USP-1042419 | Argatroban Related Compound A (15 mg) ((2R,4R)-1-[N8-nitro- N2-(3-methylquinoline-8-sulfonyl)-L-arginyl]-4-methylpiperidine-2-carboxylic acid) | 74874-10-5 | |
2935909550 | |||
USP-1042420 | Argatroban Related Compound B (20 mg) (Ethyl (4R)-1-[N^8-nitro-L-arginyl]-4-methylpiperidine-2-carboxylate dihydrochloride) | N/A | |
2933399095 | |||
USP-1042437 | Argatroban Related Compound C (20 mg) ((2R,4R)-1-[N^8-amino- N^2-(3-methyl-1,2,3,4-tetrahydroquinoline-8-sulfonyl)-L-arginyl]-4-methylpiperidine-2-carboxylic acid) | N/A | |
2935909550 | |||
USP-1042500 | L-Arginine (200 mg) | 74-79-3 | |
2925299000 | |||
USP-1042554 | Arginine Ethyl Ester Dihydrochloride (250 mg) | 36589-29-4 | |
2925299000 | |||
USP-1042601 | Arginine Hydrochloride (125 mg) | 1119-34-2 | |
2925299000 | |||
USP-1042634 | Aripiprazole (200 mg) | 129722-12-9 | |
2933790002 | |||
USP-1042645 | Aripiprazole Related Compound B (25 mg) (7-(4-hydroxy-butoxy)-3,4-dihydroquinolin-2(1H)-one) | 889443-20-3 | |
2933790002 | |||
USP-1042656 | Aripiprazole Related Compound C (25 mg) (1-(2,3-dichlorophenyl)piperazine hydrochloride) | 119532-26-2 | |
2933599550 | |||
USP-1042689 | Aripiprazole Related Compound F (25 mg) (4-(2,3-dichlorophenyl)-1-[4-(2-oxo-1,2,3,4-tetrahydroquinolin-7-yloxy)butyl]piperazin 1-oxide) | 573691-09-5 | |
2933790002 | |||
USP-1042690 | Aripiprazole Related Compound G (25 mg) (7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}quinolin-2(1H)-one) | 129722-25-4 | |
2933790002 | |||
USP-1042703 | Arsanilic Acid (25 mg) | 98-50-0 | UN3465 |
USP-1042714 | Aripiprazole Related Compound H (25 mg) (7-(4-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}butoxy)-3,4-dihydroquinolin-2(1H)-one) | N/A | |
2933790002 | |||
USP-1042747 | Artemisinin (50 mg) ((3R,5aS,6R,8aS,9R,12S,12aR)-Octahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10(3H)-one) | 63968-64-9 | |
2932206000 | |||
USP-1042780 | Artemether (100 mg) | 71963-77-4 | |
2932999000 | |||
USP-1042805 | Artemether Related Compound B (15 mg) ((3R,5aS,6R,8aS,9R,10R,12R,12aR)-Decahydro-10-methoxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin) | 71939-51-0 | |
2932999000 | |||
USP-1042850 | Artesunate (200 mg) | 88495-63-0 | |
2932999000 | |||
USP-1042907 | Articaine (40 mg) | 23964-58-1 | |
2934990005 | |||
USP-1042918 | Articaine Hydrochloride (125 mg) | 23964-57-0 | |
2934990005 | |||
USP-1042929 | Articaine Related Compound A (40 mg) (Methyl 4-methyl-3-[2-(propylamino)acetamido]thiophene-2-carboxylate) | N/A | |
2934990005 | |||
USP-1042930 | Articaine Related Compound B (25 mg) (4-methyl-3-{[2-(propylamino)propanoyl]amino}thiophene-2-carboxylic acid) | 114176-52-2 | |
2934990005 | |||
USP-1042962 | Articaine Related Compound E (40 mg) (Methyl 3-[2-(isopropylamino)propanamido]-4-methylthiophene-2-carboxylate) | 1796888-45-3 | |
2934990005 | |||
USP-1043003 | Ascorbic Acid (1 g) (Vitamin C) | 50-81-7 | |
2936270000 | |||
USP-1043105 | Ascorbyl Palmitate (500 mg) | 137-66-6 | |
2936270000 | |||
USP-1043149 | Ascorbyl Stearate (500 mg) | 10605-09-1 | |
2936270000 | |||
USP-1043309 | Powdered Ashwagandha Root Extract (1 g) | 90147-43-6 | |
1302190200 | |||
USP-1043331 | Asiaticoside (30 mg) | 16830-15-2 | |
2938900000 | |||
USP-1043502 | Asparagine Anhydrous (200 mg) | 70-47-3 | |
2924190002 | |||
USP-1043513 | Asparagine Monohydrate (200 mg) | 5794-13-8 | |
2924190002 | |||
USP-1043524 | Asparagine Related Compound A (10 mg) (2,2′-(3,6-dioxopiperazine-2,5-diyl)diacetamide) | 98490-54-1 | |
2933790002 | |||
USP-1043706 | Aspartame (200 mg) | 22839-47-0 | |
2924296000 | |||
USP-1043728 | Aspartame Related Compound A (25 mg) ([(2S,5S)-5-Benzyl-3,6-dioxopiperazin-2-yl]acetic acid) | 5262/10/2 | |
2933599550 | |||
USP-1043750 | Aspartame Acesulfame (200 mg) | 106372-55-8 | |
2934990005 | |||
USP-1043819 | Aspartic Acid (100 mg) | 56-84-8 | |
2922498050 | |||
USP-1044006 | Aspirin (500 mg) | 50-78-2 | |
2918220000 | |||
USP-1044108 | Astragaloside IV (100 mg) ((3beta,6alpha,9beta,16beta,20R,24S)-16,25-Dihydroxy-3-(beta-D-xylopyranosyloxy)-20,24-epoxy-9,19-cyclolanostan-6-yl beta-D-glucopyranoside) | 84687-43-4 | |
2932996560 | |||
USP-1044119 | Astragalus Root Dry Extract (1 g) | N/A | |
1302190200 | |||
USP-1044254 | Atenolol Related Compound A (50 mg) (2-(4-Hydroxyphenyl)acetamide) | 17194-82-0 | |
2924296000 | |||
USP-1044265 | Atenolol Related Compound B (25 mg) (2-[4-(2,3-Dihydroxypropoxy)phenyl]acetamide) | 61698-76-8 | |
2924296000 | |||
USP-1044276 | Atenolol Related Compound C (25 mg) (2-[4-(Oxiran-2-ylmethoxy)phenyl]acetamide) | 29122-69-8 | |
2924296000 | |||
USP-1044287 | Atenolol Related Compound D (25 mg) (2-[4-(3-Chloro-2-hydroxypropoxy)phenyl]acetamide) | 115538-83-5 | |
2924296000 | |||
USP-1044298 | Atenolol Related Compound E (25 mg) (2,2′-{[(2-Hydroxypropane-1,3-diyl)bis(oxy)]bis(4,1-phenylene)}diacetamide) | 141650-31-9 | |
2924296000 | |||
USP-1044334 | Atazanavir Sulfate (200 mg) | 229975-97-7 | |
2933399095 | |||
USP-1044345 | Atazanavir System Suitability Mixture (25 mg) (A mixture of atazanavir sulfate, atazanavir R, S, S, S,-diastereomer and atazanavir S,R,S,S diastereomer) | N/A | |
2933399095 | |||
USP-1044356 | Atazanavir Related Compound A (25 mg) ((S)-2-[(Methoxycarbonyl)amino]-3,3-dimethylbutanoic acid) | 162537-11-3 | |
2924190002 | |||
USP-1044367 | Atenolol Related Compound F (25 mg) (2,2′-[{[(Isopropylazanediyl)bis(2-hydroxypropane-3,1-diyl)]bis(oxy)}bis(4,1-phenylene)]diacetamide) | 87619-83-8 | |
2924296000 | |||
USP-1044403 | Atenolol (200 mg) | 29122-68-7 | |
2924296000 | |||
USP-1044469 | Atomoxetine Hydrochloride (200 mg) | 82248-59-7 | UN2811 |
USP-1044470 | Atomoxetine Related Compound A (10 mg) (3-(Methylamino)-1-phenylpropan-1-ol) | 42142-52-9 | |
2922199695 | |||
USP-1044488 | Atomoxetine Related Compound B (10 mg) (N-Methyl-3-phenyl-3-(m-tolyloxy)propan-1-amine hydrochloride) | 1643684-05-2 | |
2922199695 | |||
USP-1044491 | Atomoxetine Related Compound C (10 mg) (N-methyl-3-phenyl-3-(p-tolyloxy)propan-1-amine hydrochloride) | 873310-31-7 | |
2922199695 | |||
USP-1044516 | Atorvastatin Calcium (100 mg) | 344423-98-9 | |
2933995300 | |||
USP-1044527 | Atorvastatin Related Compound A (20 mg) (Desfluoro impurity, or (3R,5R)-7-[3-(phenylcarbamoyl)-2-isopropyl-4,5-diphenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid calcium salt) | 433289-83-9 | |
2933997500 | |||
USP-1044538 | Atorvastatin Related Compound B (20 mg) (Calcium (3S,5R)-7-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate (1:2)) | 887196-25-0 | |
2933997500 | |||
USP-1044549 | Atorvastatin Related Compound C (20 mg) (Calcium (3R,5R)-7-[2,3-Bis(4-fluorophenyl)-5-isopropyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate (1:2)) | 693793-53-2 | |
2933998350 | |||
USP-1044550 | Atorvastatin Related Compound D (10 mg) (Epoxide Impurity, 3-(4-Fluorobenzoyl)-2-isobutyryl-N,3-diphenyloxirane-2-carboxamide) | 148146-51-4 | |
2924296000 | |||
USP-1044571 | Atorvastatin Related Compound E (10 mg) (Calcium(3S,5S)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate (1:2)) | 1105067-88-6 | |
2933998350 | |||
USP-1050982 | Benzalkonium Bromide (C12) (150 mg) (Benzyldodecyldimethylammonium bromide) (需冷链运输) | 7281/4/1 | UN2928 |
USP-1051500 | Benzethonium Chloride (500 mg) | 121-54-0 | UN2923 |
USP-1051602 | Benzhydrol (50 mg) | 91-01-0 | |
2906290000 | |||
USP-1054000 | Benzocaine (500 mg) | 1994/9/7 | |
2922492050 | |||
USP-1055002 | Benzoic Acid (300 mg) | 65-85-0 | UN3077 |
USP-1056130 | Benzophenone (25 mg) (Diphenylmethanone) | 119-61-9 | UN3077 |
USP-1056504 | 1,4-Benzoquinone (200 mg) | 106-51-4 | UN2587 |
USP-1057507 | Benzothiadiazine Related Compound A (100 mg) (4-Amino-6-chloro-1,3-benzenedisulfonamide) | 121-30-2 | |
2935909550 | |||
USP-1059058 | Benzphetamine Related Compound E (30 mg) ((1S,2S)-2-[Benzyl(methyl)amino]-1-phenylpropan-1-ol hydrochloride) | 1591807-86-1 | |
2922190900 | |||
USP-1059069 | Benzphetamine Related Compound F (25 mg) ((1S,2S)-2-[Benzyl(methyl)amino]-1-cyclohexylpropan-1-ol hydrochloride) | 1591761-34-0 | |
2922190900 | |||
USP-1061027 | Benztropine Related Compound A (50 mg) ((1R,3r,5S)-3-(Benzhydryloxy)-8-azabicyclo[3.2.1]octane hydrochloride) | 25471-67-4 | |
2939800000 | |||
USP-1298117 | Granisetron Related Compound A (15 mg) (2-methyl-N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-2H-indazole-3-carboxamide) | 127472-42-8 | |
2933399095 | |||
USP-1298128 | Granisetron Related Compound B (15 mg) (N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide) | 107007-95-4 | |
2933399095 | |||
USP-1298139 | Granisetron Related Compound C (15 mg) (N-[(1R,3r,5S)-9-azabicyclo[3.3.1]non-3-yl]-1-methyl-1H-indazole-3-carboxamide hydrochloride) | 141136-01-8 | |
2933399095 | |||
USP-1298140 | Granisetron Related Compound D (15 mg) (1-Methyl-1H-indazole-3-carboxylic acid) | 50890-83-0 | |
2933998350 | |||
USP-1298150 | Granisetron Related Compound E (15 mg) ((1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine acetate) | N/A | |
2933399095 | |||
USP-1298208 | Grape Seeds Oligomeric Proanthocyanidins (500 mg) | NA | |
3824995595 | |||
USP-1298219 | Purified Grape Seeds Oligomeric Proanthocyanidins (500 mg) | N/A | |
3824995595 | |||
USP-1298401 | Powdered Decaffeinated Green Tea Extract (300 mg) | 84650-60-2 | |
2101200040 | |||
USP-1299007 | Griseofulvin (200 mg) | 126-07-8 | |
2941906000 | |||
USP-1299200 | Griseofulvin Permeability Diameter (2 g) | 126-07-8 | |
2941906000 | |||
USP-1301007 | Guaifenesin (200 mg) | 93-14-1 | |
2909490000 | |||
USP-1301404 | Guanabenz Acetate (200 mg) | 23256-50-0 | UN2811 |
USP-1301801 | Guanethidine Monosulfate (200 mg) | 645-43-2 | |
2933999552 | |||
USP-1302101 | Guanfacine Hydrochloride (125 mg) | 29110-48-3 | UN2811 |
USP-1302134 | Guanidine Hydrochloride (100 mg) | 1950/1/1 | |
2925299000 | |||
USP-1302156 | Guanine (100 mg) | 73-40-5 | |
2933599550 | |||
USP-1340086 | Indole (25 mg) | 120-72-9 | UN2811 |
USP-1340960 | Inositol (500 mg) | 87-89-8 | |
2906130000 | |||
USP-1341001 | Indomethacin (200 mg) | 53-86-1 | UN2811 |
USP-1343007 | Iodipamide (200 mg) | 606-17-7 | |
2924296000 | |||
USP-1343517 | Iodixanol (200 mg) | 92339-11-2 | |
2924296000 | |||
USP-1343540 | Iodixanol Related Compound C (25 mg) (5-[Acetyl[3-[[3,5-bis[[(2,3-dihydroxypropyl)amino]carbonyl]-2,4,6-triiodophenyl]amino]-2-hydroxypropyl]amino]-N,N’-bis-(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide) | 171897-74-8 | |
2924296000 | |||
USP-1343550 | Iodixanol Related Compound D (50 mg) (5-[Acetyl(2-hydroxy-3-methoxypropyl)amino]-N,N’-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide) | 89797-00-2 | |
2924296000 | |||
USP-1343561 | Iodixanol Related Compound E (25 mg) (5-{N-[3-(N-{3-carbamoyl-5-[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl}acetamido)-2-hydroxypropyl]acetamido}-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide) | 255376-57-9 | |
2924296000 | |||
USP-1344305 | o-Iodohippuric Acid (100 mg) | 147-58-0 | |
2924296000 | |||
USP-1344509 | Iodoquinol (100 mg) | 83-73-8 | |
2933492250 | |||
USP-1344600 | Iohexol (550 mg) | 66108-95-0 | |
2924296000 | |||
USP-1344622 | Iohexol Related Compound A (100 mg) (5-(acetylamino)-N,N’-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide) | 31127-80-7 | |
2924296000 | |||
USP-1344644 | Iohexol Related Compound B (50 mg) (5-amino-N,N’-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide) | 76801-93-9 | |
2924296000 | |||
USP-1344666 | Iohexol Related Compound C (50 mg) (N,N’-bis(2,3-dihydroxypropyl)-5-nitro-1,3-benzenedicarboxamide) | N/A | |
2924296000 | |||
USP-1344702 | Iopamidol (200 mg) | 60166-93-0 | |
2924296000 | |||
USP-1344724 | Iopamidol Related Compound A (50 mg) (N,N’-Bis-(1,3-dihydroxy-2-propyl)-5-amino-2,4,6-triiodoisophthalamide) | 60166-98-5 | |
2924296000 | |||
USP-1344735 | Iopamidol Related Compound B (50 mg) (5-Glycolamido-N,N’-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-2,4,6-triiodoisophthalamide) | N/A | |
2924296000 | |||
USP-1344746 | Iopamidol Related Compound C (40 mg) (4-chloro-N1, N3-bis(1,3-dihydroxypropan-2-yl)-5-(S)-lactamido-2,6-diiodoisophthalamide) | NA | |
2924296000 | |||
USP-1344804 | Iopromide (400 mg) | 73334-07-3 | |
2924296000 | |||
USP-1344826 | Iopromide Related Compound A (50 mg) (5-Amino-N1,N3-Bis-(2,3-dihydroxypropyl)-2,4,6-triiodo-N1-methylisophthalamide) | 154361-51-0 | |
2924296000 | |||
USP-1344837 | Iopromide Related Compound B (50 mg) (5-(Acetylamino)-N,N’-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methyl-1,3-benzenedicarboxamide) | 76350-28-2 | |
2924296000 | |||
USP-1345002 | Iothalamic Acid (200 mg) | 2276-90-6 | |
2924296000 | |||
USP-1345104 | Ioversol (200 mg) | 87771-40-2 | |
2924296000 | |||
USP-1345159 | Ioxaglic Acid (100 mg) | 59017-64-0 | |
2924296000 | |||
USP-1345206 | Ioxilan (400 mg) | 107793-72-6 | |
2924296000 | |||
USP-1347507 | Ipratropium Bromide (200 mg) | 66985-17-9 | |
2939790000 | |||
USP-1347529 | Ipratropium Bromide Related Compound B (10 mg) ((1R,3r,5S,8s)-3-[[(2RS)-3-hydroxy-2-phenylpropanoyl]oxy]-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane, bromide) | 58073-59-9 | |
2939800000 | |||
USP-1347530 | Ipratropium Bromide Related Compound C (15 mg) ((2-RS)-3-hydroxy-2-phenylpropanoic acid) | 552-63-6 | |
2918195000 | |||
USP-1347609 | Irinotecan Hydrochloride (100 mg) | 136572-09-3 | |
2939800000 | |||
USP-1347610 | Irinotecan Related Compound A (10 mg) ((S)-4-ethyl-4,9-dihydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione) | 19685-09-7 | |
2939800000 | |||
USP-1347631 | Irinotecan Related Compound B (10 mg) ((S)-4,11-diethyl-4,9-dihydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione) | 86639-52-3 | |
2939800000 | |||
USP-1347642 | Irinotecan Related Compound C (10 mg) (11-Ethyl-4-hydroxy-4-methyl-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-9-yl (1,4′-bipiperidine)- 1′-carboxylate hydrochloride) | N/A | |
2939800000 | |||
USP-1347653 | Irinotecan Related Compound D (15 mg) ((R)-9-[(1,4′-Bipiperidine)-1′-carbonyloxy]-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline hydrochloride, trihydrate) | N/A | |
2939800000 | |||
USP-1347664 | Irinotecan Related Compound E (15 mg) ((S)-4,11-Diethyl-4-hydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione) | 78287-27-1 | |
2939790000 | |||
USP-1347700 | Irbesartan (200 mg) | 138402-11-6 | |
2933995300 | |||
USP-1347711 | Irbesartan Related Compound A (25 mg) (1-pentanoylamino-cyclopentanecarboxylic acid [2′-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amide) | 748812-53-5 | |
2933998350 | |||
USP-1347813 | Isobutylidene Diurea (300 mg) (1,1′-(2-Methylpropane-1,1-diyl)diurea) | 6104-30-9 | |
2924190002 | |||
USP-1348033 | Isochlorogenic Acid A (50 mg) | 89919-62-0 | |
2918290000 | |||
USP-1348543 | Isoeugenyl Acetate (150 mg) | 93-29-8 | |
2915399500 | |||
USP-1348601 | Red Clover Aerial Parts Isoflavone Aglycones Dry Extract (500 mg) | N/A | |
1302190200 | |||
USP-1348907 | Isoflupredone Acetate (200 mg) | 338-98-7 | |
2937220000 | |||
USP-1606117 | Rotigotine Related Compound C (25 mg) ((S)-6-{[2-(Thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride) | N/A | |
2934990005 | |||
USP-1606140 | Rotigotine Related Compound G (25 mg) ((S)-6-{Bis[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride) | N/A | |
2934990005 | |||
USP-1606208 | Roxarsone (200 mg) | 121-19-7 | UN3465 |
USP-1606401 | Rufinamide (200 mg) | 106308-44-5 | |
2933996500 | |||
USP-1606412 | Rufinamide Related Compound A (25 mg) (1-(2-Fluorobenzyl)-1H-1,2,3-triazole-4-carboxamide) | 106308-41-2 | |
2933998350 | |||
USP-1606423 | Rufinamide Related Compound B (25 mg) (Methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate) | 217448-86-7 | |
2933998350 | |||
USP-1606503 | Rutin (100 mg) | 250249-75-3 | |
2938100000 | |||
USP-1607007 | Saccharin (200 mg) | 1981/7/2 | |
2925110000 | |||
USP-1607029 | Saccharin Calcium (150 mg) | 6485-34-3 | |
2925110000 | |||
USP-1607040 | Saccharin Sodium (200 mg) | 6155-57-3 | |
2925110000 | |||
USP-1607506 | Powdered St. John’s Wort Extract (600 mg) | 84082-80-4 | |
1302190200 | |||
USP-1607903 | D-Salicin (150 mg) | 138-52-3 | |
2938900000 | |||
USP-1608000 | Salicylamide (200 mg) | 65-45-2 | |
2924296000 | |||
USP-1609002 | Salicylic Acid (125 mg) | 69-72-7 | |
2918215100 | |||
USP-1609013 | Salicylic Acid Related Compound A (100 mg) (4-hydroxybenzoic acid) | 99-96-7 | |
2918290000 | |||
USP-1612426 | Sesame Oil Related Compound B (12 mg x 2 vials) ((1,2-Dilinoleoyl-3-palmitoyl-rac-glycerol) (PLL)) | 2190-15-0 | |
1516200100 | |||
USP-1612459 | Sevelamer Carbonate (100 mg) | 845273-93-0 | |
3911906100 | |||
USP-1612506 | L-Serine (200 mg) | 56-45-1 | |
2922505000 | |||
USP-1612517 | Sertraline Hydrochloride Racemic Mixture (30 mg) ((1RS,4RS)-4-(3,4-Dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthylamine hydrochloride) | 79617-89-3 | UN3077 |
USP-1612528 | Sertraline Hydrochloride Related Compound A (25 mg) ((1RS,4SR)-4-(3,4-Dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthylamine hydrochloride) | N/A | |
2921490002 | |||
USP-1612539 | Sertraline Hydrochloride (100 mg) | 79559-97-0 | UN3077 |
USP-1612561 | Sildenafil Citrate (100 mg) | 171599-83-0 | |
2933595960 | |||
USP-1612608 | Silver Sulfadiazine (200 mg) | 22199-08-2 | |
2843290100 | |||
USP-1612619 | N-Acetylneuraminic Acid (200 mg) | 131-48-6 | |
2932999000 | |||
USP-1612630 | Silybin (50 mg) | 22888-70-6 | |
2932996560 | |||
USP-1612641 | Silydianin (30 mg) | 29782-68-1 | |
2932996560 | |||
USP-1612685 | Sildenafil Related Compound A (10 mg) (1-{[3-(6,7-Dihydro-1-methyl-7-oxo-3-isobutyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl}-4-methylpiperazine) | 1391053-95-4 | |
2933599550 | |||
USP-1612700 | Simvastatin (200 mg) | 79902-63-9 | UN3077 |
USP-1612743 | Sirolimus System Suitability Mixture (15 mg) | N/A | UN3077 |
USP-1612765 | Sirolimus (50 mg) | 53123-88-9 | UN3077 |
USP-1612801 | Sisomicin Sulfate (500 mg) | 53179-09-2 | |
2941901010 | |||
USP-1612856 | Sibutramine Related Compound A (20 mg) (N-{1-[1-(2-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine hydrochloride) | N/A | |
2921490002 | |||
USP-1614363 | Sodium Lauryl Sulfate (1 g) | 151-21-3 | UN1325 |
USP-1614374 | Sodium Lauroyl Sarcosinate (150 mg) | 137-16-6 | UN2811 |
USP-1614385 | Sodium Myristoyl Sarcosinate (30 mg) (Sodium N-methyl-N-tetradecanoylglycinate) | 30364-51-3 | UN2811 |
USP-1614396 | Sodium Metabisulfite (2 X 500 mg) | 7681-57-4 | |
2832100000 | |||
USP-1614421 | Sodium Molybdate Dihydrate (200 mg) | 10102-40-6 | |
2841700000 | |||
USP-1614454 | Sodium Nitrite (1 g) | 7632-00-0 | UN1500 |
USP-1614501 | Sodium Nitroprusside (500 mg) | 13755-38-9 | UN1588 |
USP-1614512 | Sodium Phenylbutyrate (200 mg) | 1716-12-7 | |
2916399000 | |||
USP-1614523 | Phenylbutyrate Related Compound A (25 mg) (4-oxo-4-phenylbutanoic acid) | 2051-95-8 | |
2918300000 | |||
USP-1235820 | Enoxaparin Sodium (300 mg) | 679809-58-6 | |
3001900190 | |||
USP-1235853 | Enoxaparin Sodium Molecular Weight Calibrant A (8.0 mg) | N/A | |
3001900190 | |||
USP-1235864 | Enoxaparin Sodium Molecular Weight Calibrant B (6.0 mg) | 9041/8/1 | |
3001900190 | |||
USP-1235900 | Enrofloxacin (200 mg) | 93106-60-6 | UN3077 |
USP-1235911 | Enrofloxacin Related Compound Mixture (50 mg) | N/A | UN3077 |
USP-1235933 | Entacapone (200 mg) | 130929-57-6 | |
2926900005 | |||
USP-1235944 | Entacapone Related Compound A (25 mg) ((Z)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide) | 145195-63-7 | |
2926900005 | |||
USP-1235966 | Entecavir Monohydrate (200 mg) | 209216-23-9 | |
2933595960 | |||
USP-1235977 | Entecavir Related Compound A (15 mg) (9-[(1S,3R,4S)-4-Dimethylphenylsilyl-3-(benzyloxymethyl)-2-methylenecyclopentyl]guanine) | 649761-24-0 | |
2933599550 | |||
USP-1235988 | Entecavir System Suitability Mixture (15 mg) (This is a mixture containing entecavir 1-epimer (0.2%), entecavir (99.6%), 8-hydroxy entecavir (0.1%), and 8-methoxy entecavir (0.1%)) | 1367369-78-5 | |
3822190000 | |||
USP-1236506 | 4-Epianhydrotetracycline Hydrochloride (50 mg) | 4465-65-0 | |
2941300000 | |||
USP-1236620 | (-)-Epicatechin (50 mg) | 490-46-0 | |
2932996560 | |||
USP-1236663 | Epicoprostanol (200 mg) | 516-92-7 | |
2906130000 |
美国药典USP标准品CAS编号查询(三十一),USP标准物质代理
USP订购编号 | 美国药典,USP分析标准品,英文名称,规格 | CAS编号查询 | UN编号对照 |
USP-1269378 | Febantel Related Compound B (15 mg) (2-(Methoxymethyl)-5-(phenylthio)-1H-benzimidazole) | 92114-71-1 | |
2933998350 | |||
USP-1269389 | Felodipine (300 mg) | 72509-76-3 | UN3077 |
USP-1269390 | Felodipine Related Compound A (15 mg) (3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate) | 96382-71-7 | |
2933399095 | |||
USP-1269403 | Fenbendazole (100 mg) | 43210-67-9 | |
2933994600 | |||
USP-1269414 | Fenbendazole Related Compound A (30 mg) (Methyl (1H-benzimidazole-2-yl)carbamate) | 10605-21-7 | UN3077 |
USP-1269425 | Fenbendazole Related Compound B (30 mg) (Methyl [5(6)-chlorobenzimidazole-2-yl]carbamate) | 20367-38-8 | |
2933997500 | |||
USP-1269436 | Fenofibric Acid (250 mg) (2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropanoic acid) | 42017-89-0 | |
2918992090 | |||
USP-1269447 | Fenofibrate (200 mg) | 49562-28-9 | |
2918992090 | |||
USP-1269458 | Fenoldopam Mesylate (200 mg) | 67227-57-0 | |
2933995300 | |||
USP-1269469 | Fenoldopam Related Compound A (20 mg) (N-Methyl-6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H-3-benzazepine-7,8-diol hydrochloride) | N/A | |
2933997500 | |||
USP-1269470 | Fenoldopam Related Compound B (20 mg) (1-(4-Hydroxyphenyl)-2,3,4,5-tetrahydro-1H-benzo[d]azepine-7,8-diol methanesulfonate) | N/A | |
2933998350 | |||
USP-1269505 | Fenoprofen Calcium (500 mg) | 71720-56-4 | |
2918992090 | |||
USP-1269550 | Fenoprofen Sodium (500 mg) | 66424-46-2 | |
2918992090 | |||
USP-1269607 | Fenofibrate Related Compound A (25 mg) ((4-Chlorophenyl)(4-hydroxyphenyl)methanone) | 42019-78-3 | |
2914710000 | |||
USP-1269618 | Fenofibrate Related Compound B (25 mg) (2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid) | 42017-89-0 | |
2918992090 | |||
USP-1269629 | Fenofibrate Related Compound C (25 mg) (1-methylethyl 2-[[2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoyl]oxy]-2-methylpropanoate) | 217636-48-1 | |
2918992090 | |||
USP-1269924 | Fentanyl Related Compound B (10 mg) (4-Anilinopiperidine) | 23056-29-3 | |
2933399095 | |||
USP-1269946 | Fentanyl Related Compound D (10 mg) (N-Phenyl-1-(phenylmethyl)-4-piperidinamine) | 1155-56-2 | |
2933399095 | |||
USP-1270231 | Trigonella Foenum-graecum Seed Dry Extract (1 g) | N/A | |
1302190200 | |||
USP-1270311 | Ferulic Acid (25 mg) ((E)-3-(4-hydroxy-3-methoxyphenyl)acrylic acid) | 537-98-4 | |
2918992090 | |||
USP-1270355 | Ferrous Sulfate (2 x 1 g) | 7782-63-0 | UN3077 |
USP-1270363 | Fexofenadine (200 mg) (2-(4-{1-Hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl}phenyl)-2-methylpropanoic acid dihydrate) | 885946-90-7 | |
2933399095 | |||
USP-1270377 | Fexofenadine Hydrochloride (200 mg) | 153439-40-8 | |
2933399095 | |||
USP-1270388 | Fexofenadine Related Compound A (25 mg) (2-(4-{4-[4-(Hydroxydiphenylmethyl)piperidin-1-yl]butanoyl}phenyl)-2-methylpropanoic acid) | 76811-98-8 | |
2933399095 | |||
USP-1270399 | Fexofenadine Related Compound B (25 mg) (2-(3-{1-Hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl}phenyl)-2-methylpropanoic acid hydrochloride monohydrate) | N/A | |
2933399095 | |||
USP-1270402 | Finasteride (200 mg) | 98319-26-7 | |
2937290000 | |||
USP-1270446 | Fexofenadine Related Compound C (25 mg) ((+/-)-4-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-butyl]-isopropylbenzene hydrochloride) | N/A | |
2933399095 | |||
USP-1270480 | Fingolimod Hydrochloride (300 mg) | 162359-56-0 | UN3077 |
USP-1270526 | Fingolimod System Suitability Mixture (40 mg) | N/A | UN3077 |
USP-1270708 | Flavoxate Hydrochloride (200 mg) | 3717-88-2 | |
2934990005 | |||
USP-1270719 | Flavoxate Related Compound A (25 mg) (3-methylflavone-8-carboxylic acid) | 3468/1/7 | |
2932996560 | |||
USP-1270720 | Flavoxate Related Compound B (20 mg) (Methyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate) | 90101-87-4 | |
2932996560 | |||
USP-1283313 | Foscarnet Related Compound B (10 mg) (disodium (ethoxyoxidophosphanyl)formate) | N/A | |
2931490000 | |||
USP-1012633 | Albuterol Sulfate (200 mg) | 51022-70-9 | |
2922504500 | |||
USP-1012644 | Albuterol Related Compound A (25 mg) (4-[2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]-2-methylphenol sulfate) | 2044704-57-4 | |
2922504500 | |||
USP-1012655 | Albuterol Related Compound B (10 mg) (2-(tert-butylamino)-1-[4-hydroxy-3-(hydroxymethyl)phenyl]ethanone) | 156547-62-5 | |
2922504500 | |||
USP-1012689 | Albuterol Related Compound E (10 mg) (2,2′-oxybis(methylene)bis{4-[2-(tert-butylamino)-1-hydroxyethyl]phenol} diacetate) | N/A | |
2922504500 | |||
USP-1012746 | Alclometasone Dipropionate Related Compound A (20 mg) (11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate) | N/A | |
2937290000 | |||
USP-1012757 | Alclometasone Dipropionate (300 mg) | 66734-13-2 | |
2937220000 | |||
USP-1012780 | Alendronate Sodium (200 mg) | 121268-17-5 | |
2931909000 | |||
USP-1012799 | Aleuritic Acid (50 mg) | 533-87-9 | |
2918195000 | |||
USP-1012848 | Alitame (250 mg) | 99016-42-9 hydrated | |
2934990005 | |||
USP-1012859 | Alitame – Alanine Amide Impurity (25 mg) (N-(2,2,4,4-tetramethyl-3-thietanyl)-D-alanimamide) | 80875-07-6 | |
2934990005 | |||
USP-1012871 | Alfuzosin System Suitability Mixture A (25 mg) (Alfuzosin Hydrochloride containing Impurity A, Impurity D, and Impurity E) | N/A | |
3822190000 | |||
USP-1012917 | Alfuzosin Hydrochloride (150 mg) | 81403-68-1 | |
2934990005 | |||
USP-1012928 | Alfuzosin System Suitability Mixture (15 mg) | N/A | |
3822190000 | |||
USP-1012939 | Allantoin (200 mg) | 97-59-6 | |
2933210000 | |||
USP-1012941 | Alginic Acid (100 mg) | 9005-32-7 | |
3913100000 | |||
USP-1012950 | Alliin (25 mg) | 556-27-4 | |
2930904990 | |||
USP-1013002 | Allopurinol (250 mg) | 315-30-0 | UN3077 |
USP-1013013 | Allopurinol Related Compound B (25 mg) (5-(formylamino)-1H-pyrazole-4-carboxamide) | 22407-20-1 | |
2933199050 | |||
USP-1013024 | Allopurinol Related Compound A (25 mg) (3-Amino-4-carboxamidopyrazole Hemisulfate) | 27511-79-1 | |
2933199050 | |||
USP-1013035 | Allopurinol Related Compound C (25 mg) (5-(4H-1,2,4-triazol-4-yl)-1H-pyrazole-4-carboxamide) | 1346604-13-4 | |
2933199050 | |||
USP-1013046 | Allopurinol Related Compound D (35 mg) (Ethyl 5-amino-1H-pyrazole-4-carboxylate) | 6994-25-8 | UN3077 |
USP-1013057 | S-Allyl-L-Cysteine (25 mg) | 21593-77-1 | |
2930904990 | |||
USP-1013068 | Allopurinol Related Compound E (25 mg) (ethyl 5-(formylamino)-1H-pyrazole-4-carboxylate) | 31055-19-3 | |
2933199050 | |||
USP-1013079 | Allopurinol Related Compound F (25 mg) (ethyl-(E/Z)-3-(2-carbethoxy-2-cyanoethenyl)amino-1H-pyrazole-4-carboxylate) | 321571-07-7 | |
2933199050 | |||
USP-1013115 | Allulose (200 mg) | 551-68-8 | |
2940006000 | |||
USP-1013512 | Almotriptan Malate (200 mg) | 181183-52-8 | |
2935904000 | |||
USP-1013523 | Almotriptan Related Compound A (20 mg) ({3-[2-(Dimethylamino)ethyl]-5-[(pyrrolidine-1-yl)sulfonylmethyl]-1H-indol-1-yl}methanol) | 1018676-02-2 | |
2935909550 | |||
USP-1013534 | Almotriptan System Suitability (20 mg) (Mixture of Almotriptan Malate and Almotriptan Monomethyl Analog) | N/A | |
2935909550 | |||
USP-1013545 | Almotriptan Related Compound B (15 mg) (2-{5-[(pyrrolidin-1-ylsulfonyl)methyl]-1H-indol-3-yl}ethanamine hemifumarate) | 1246860-65-0 | |
2933997500 | |||
USP-1457797 | Nebivolol Stereoisomer Mixture (15 mg) | N/A | UN3077 |
USP-1457833 | Nebivolol Hydrochloride (150 mg) | 152520-56-4 | UN3077 |
USP-1457855 | Nebivolol Related Compound A (30 mg) (See USP Certificate for full Chemical Name) | N/A | |
2932996560 | |||
USP-1457866 | Nebivolol Related Compound B (30 mg) (See USP Certificate for full Chemical Name) | N/A | |
2932996560 | |||
USP-1457877 | Nebivolol Related Compound C (100 mg) (需冷链运输) ((RS)-6-Fluoro-2-[(RS)-oxiran-2-yl]chroman) | 876514-31-7 | UN3077 |
USP-1457888 | Nebivolol Related Compound D (100 mg) ((RS)-6-Fluoro-2-[(SR)-oxiran-2-yl]chroman) | 793669-26-8 | UN3077 |
USP-1457899 | Nebivolol Related Compound E (30 mg) (1-(Chroman-2-yl)-2-((2-(6-fluorochroman-2-yl)-2-hydroxyethyl)amino)ethanol hydrochloride) | N/A | |
2932996560 | |||
USP-1457902 | Nefazodone Hydrochloride (200 mg) | 82752-99-6 | |
2933595960 | |||
USP-1457913 | Nefazodone Related Compound A (25 mg) (1-(3-chlorophenyl)-4-(3-chloropropyl)-piperazine hydrochloride) | 57059-62-8 | |
2933599550 | |||
USP-1457924 | Nefazodone Related Compound B (25 mg) (2-[3-[4-(4-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one hydrochloride) | N/A | |
2933599550 | |||
USP-1458019 | Neomycin B (150 mg) | 28002-70-2 | |
2941906000 | |||
USP-1458020 | Neomycin A (2.5 mg) | 3947-65-7 (free base) | |
2940006000 | |||
USP-1458031 | Neomycin Sulfate System Suitability Mixture (100 mg) | N/A | |
2941901010 | |||
USP-1458042 | Neohesperidin (30 mg) ((S)-5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 2-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranoside) | 13241-33-3 | |
2938900000 | |||
USP-1458064 | Neodiosmin (30 mg) (5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-4H-chromen-7-yl 2-O-(alpha-L-rhamnopyranosyl)-beta-Dglucopyranoside) | 38665-01-9 | |
2938900000 | |||
USP-1478833 | Orlistat Related Compound C (25 mg) (Triphenylphosphine oxide) | 791-28-6 | |
2931490000 | |||
USP-1478855 | Orlistat Related Compound E (10 mg) (N-Formyl (S)-isoleucine (S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester) | 1072902-75-0 | |
2932206000 | |||
USP-1479009 | Orphenadrine Citrate (200 mg) | 4682-36-4 | UN2811 |
USP-1479010 | Orphenadrine Related Compound A (50 mg) ((RS)-N,N-dimethyl-2-[(3-methylphenyl)-phenylmethoxy]ethanamine citrate) (AS) | N/A | |
2922199695 | |||
USP-1479020 | Orphenadrine Related Compound B (20 mg) (N-Ethyl-N,N-dimethyl-2-[phenyl(o-tolyl)methoxy]ethanaminium chloride; also known as N-Ethyl-N,N-dimethyl-2-[phenyl(2-tolyl)methoxy]ethanaminium chloride) | 93940-17-1 | |
2923900100 | |||
USP-1479031 | Orphenadrine Related Compound C (20 mg) (N-methyl-2-[phenyl(o-tolyl)methoxy]ethanamine hydrochloride) | 10488-36-5 | |
2922190900 | |||
USP-1485114 | Oxybutynin Related Compound A (100 mg) (Phenylcyclohexylglycolic Acid) | 4335-77-7 | |
2918195000 | |||
USP-1485125 | Oxybutynin Related Compound B (20 mg) (Cyclohexyl Mandelic Acid Methyl Ester) | 10399-13-0 | |
2918195000 | |||
USP-1485136 | Oxybutynin Related Compound C (20 mg) (4-(ethylmethylamino)but-2-ynyl(+/-)-2-cyclohexyl-2-hydroxy-2-phenylacetate hydrochloride) | N/A | |
2922199695 | |||
USP-1486004 | Oxymetazoline Hydrochloride (200 mg) | 2315/2/8 | UN2811 |
USP-1486015 | Oxymetazoline Related Compound A (15 mg) (N-(2-Aminoethyl)-2-[4-(tert-butyl)-3-hydroxy-2,6-dimethylphenyl]acetamide hydrochloride) | 1391053-50-1 | |
2924296000 | |||
USP-1487029 | Oxymetholone Related Compound B (25 mg) (17Beta-Hydroxy-1-hydroxymethylene-17alpha-methyl-5alpha-androstan-3-one) | N/A | |
2914409000 | |||
USP-1490103 | Oxyquinoline Sulfate (200 mg) | 134-31-6 | |
2933492250 | |||
USP-1605045 | Roflumilast Related Compound C (50 mg) (3,5-Dichloropyridin-4-amine) | 22889-78-7 | |
2933399095 | |||
USP-1605056 | Roflumilast Related Compound D (50 mg) (3-(Cyclopropylmethoxy)-4-(difluoromethoxy)benzoic acid) | 162401-62-9 | |
2918992090 | |||
USP-1605067 | Roflumilast Related Compound E (30 mg) (N-(3-Bromo-5-chloropyridin-4-yl)-3-(cyclopropylmethoxy)-4-(difluoromethoxy)benzamide) | NA | |
2933399095 | |||
USP-1605205 | Ropinirole Hydrochloride (200 mg) | 91374-20-8 | |
2933790002 | |||
USP-1605216 | Ropinirole Related Compound A (50 mg) (4-(2-hydroxyethyl)indolin-2-one) | 139122-19-3 | |
2933790002 | |||
USP-1605227 | Ropinirole Related Compound B (50 mg) (4-[2-(Dipropylamino)ethyl]indoline-2,3-dione hydrochloride) | 221264-21-7 | |
2933790002 | |||
USP-1605497 | Ropivacaine (200 mg) | 84057-95-4 | |
2933399095 | |||
USP-1614909 | Sodium Tartrate Dihydrate (500 mg/vial; 4 vials) | 6106-24-7 | |
2918130000 | |||
USP-1615107 | Sodium Thiosulfate (1 g) | 10102-17-7 | |
2832300000 | |||
USP-1615138 | Sodium Trifluoroacetate (500 mg) | 2923-18-4 | |
2915900000 | |||
USP-1615300 | Solifenacin Succinate (100 mg) | 242478-38-2 | |
2933497050 | |||
USP-1615311 | Solifenacin Identification Mixture A (15 mg) | N/A | |
2933497050 | |||
USP-1615322 | Solifenacin Identification Mixture B (20 mg) | N/A | |
2933497050 | |||
USP-1615810 | Sophora Japonica Flower Dry Extract (500 mg) | N/A | |
1302190200 | |||
USP-1615876 | Sorafenib Tosylate (200 mg) | 475207-59-1 | |
2933399095 | |||
USP-1615887 | Sorafenib Related Compound H (25 mg) (4-(4-{3-[2-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N-methylpicolinamide) | 1431697-81-2 | |
2933399095 | |||
USP-1615956 | Sorbic Acid (1 g) | 110-44-1 | |
2916192000 | |||
USP-1616008 | 1,4-Sorbitan (300 mg) | 27299-12-3 | |
2932190002 | |||
USP-1617000 | Sorbitol (125 mg) | 50-70-4 | |
2905440000 | |||
USP-1617408 | Sotalol Hydrochloride (300 mg) | 959-24-0 | |
2935904000 | |||
USP-1617419 | Sotalol Related Compound A (50 mg) (N-[4-[[(1-Methylethyl)amino]acetyl]phenyl]methanesulfonamide monohydrochloride) | N/A | |
2935909550 | |||
USP-1617420 | Sotalol Related Compound B (50 mg) (N-(4-Formylphenyl)methanesulfonamide) | 83922-54-7 | |
2935909550 | |||
USP-1193006 | Diethylcarbamazine Citrate (200 mg) | 1642-54-2 | UN2811 |
USP-1193356 | Iscotrizinol (200 mg) | 154702-15-5 | |
2933690000 | |||
USP-1234103 | Efavirenz (200 mg) | 154598-52-4 | UN3077 |
USP-1234114 | Efavirenz Racemic (20 mg) (6-Chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one) | 177530-93-7 | |
2934990005 | |||
USP-1234125 | Efavirenz Related Compound A (20 mg) ((S)-2-(2-amino-5-chlorophenyl)-4-cyclopropyl-1,1,1-trifluorobut-3-yn-2-ol) | 209414-27-7 | |
2922199695 | |||
USP-1234136 | Efavirenz Related Compound C (20 mg) (6-chloro-2-cyclopropyl-4-(trifluoromethyl)quinoline) | 391860-73-4 | |
2933497050 | |||
USP-1234147 | Efavirenz Related Compound B (10 mg) ((S,E)-6-Chloro-4-(2-Cyclopropylvinyl)-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one) | 440124-96-9 | |
2934990005 | |||
USP-1234249 | Eflornithine Hydrochloride (150 mg) | 96020-91-6 | |
2922498050 | |||
USP-1234260 | Egeline (10 mg) | 456-12-2 | |
2924296000 | |||
USP-1234340 | European Elder Berry Dry Extract (1 g) | N/A | |
1302190200 | |||
USP-1234453 | Eletriptan Hydrobromide (200 mg) (3-[[(R)-1-Methyl-2-pyrrolidinyl]methyl]-5-[2-(phenylsulfonyl)ethyl]indole monohydrobromide monohydrate) | 273211-28-2 | |
2933995500 | |||
USP-1234475 | Eletriptan Related Compound B (20 mg) ((R)-5-Bromo-3-[(1-methylpyrrolidin-2-yl)methyl]-1H-indole) | 143322-57-0 | UN3077 |
USP-1234522 | Eletriptan S-Enantiomer (20 mg) ((S)-3-[(1-methylpyrrolidin-2-yl)methyl]-5-[2-(phenylsulfonyl)ethyl]-1H-indole, monohydrobromide) | N/A | |
2933995500 | |||
USP-1234668 | Eleutheroside B (15 mg) (Syringin) | 118-34-3 | |
2938900000 | |||
USP-1234704 | Powdered Eleuthero Extract (1.5 g) | 84696-12-5 | |
1302190200 | |||
USP-1234806 | Emedastine Difumarate (100 mg) | 87233-62-3 | |
2933992600 | |||
USP-1235004 | Emetine Hydrochloride (300 mg) | 7083-71-8 | UN1544 |
USP-1235059 | Emodin (30 mg) (1,3,8-trihydroxy-6-methylanthracene-9,10-dione) | 518-82-1 | |
2914692100 |
美国药典USP标准品CAS编号查询(三十),USP标准物质代理
USP订购编号 | 美国药典,USP分析标准品,英文名称,规格 | CAS编号查询 | UN编号对照 |
USP-1017364 | Aluminum Sulfate (2 g) | 17927-65-0 | UN3077 |
USP-1017502 | Dried Aluminum Hydroxide Gel (200 mg) | 21645-51-2 | |
2818300000 | |||
USP-1018505 | Amantadine Hydrochloride (200 mg) | 665-66-7 | UN1759 |
USP-1018516 | Amantadine Related Compound A (25 mg) (1-Chloroadamantane) | 935-56-8 | |
2903890002 | |||
USP-1018527 | Amantadine Related Compound B (25 mg) (N-(Adamantan-1-yl)acetamide) | 880-52-4 | |
2924299500 | |||
USP-1018607 | Amaranth (50 mg) | 915-67-3 | |
3204120000 | |||
USP-1019202 | Amcinonide (200 mg) | 51022-69-6 | |
2937220000 | |||
USP-1019406 | Amifostine (150 mg) | 112901-68-5 | |
2930909265 | |||
USP-1019417 | Amifostine Disulfide (100 mg) (1,3-Propanediamine, N,N-(dithiodi-2,1-ethanediyl)bis, tetrahydrochloride) | 10027-65-3 | |
2930909265 | |||
USP-1019428 | Amifostine Thiol (50 mg) (2-[(3-aminopropyl)amino]ethanethiol, dihydrochloride) | 14653-77-1 | |
2930909265 | |||
USP-1019494 | Amikacin Sulfate (100 mg) | 39831-55-5 | |
2941906000 | |||
USP-1019508 | Amikacin (300 mg) | 37517-28-5 | |
2941906000 | |||
USP-1019701 | Amiloride Hydrochloride (500 mg) | 17440-83-4 | UN2811 |
USP-1019712 | Amiloride Related Compound A (30 mg) (Methyl 3,5-diamino-6-chloropyrazine-2-carboxylate) | 1458-01-1 | |
2933997500 | |||
USP-1019756 | Aminobenzoate Potassium (200 mg) | 138-84-1 | |
2922491000 | |||
USP-1019767 | Aminobenzoate Sodium (200 mg) | 555-06-6 | |
2922491000 | |||
USP-1019803 | Aminobenzoic Acid (200 mg) (p-aminobenzoic acid) | 150-13-0 | |
2922491000 | |||
USP-1019870 | 4-Aminobenzoylglutamic Acid (50 mg) | 4271-30-1 | |
2924296000 | |||
USP-1020023 | Gamma-Aminobutyric Acid (50 mg) | 1956/12/2 | |
2922498050 | |||
USP-1021000 | Aminocaproic Acid (200 mg) | 60-32-2 | |
2922498050 | |||
USP-1021204 | 4-Aminophenol (100 mg) | 123-30-8 | UN2512 |
USP-1021292 | Aminotriazinone (300 mg) (3-Amino-1,2,4-triazin-5(2H)-one) | 1121-90-0 | |
2933690000 | |||
USP-1021703 | Nitrofurantoin Related Compound A (20 mg) (N-(Aminocarbonyl)-N-[([5-nitro-2-furanyl]-methylene)-amino]-glycine) | 63981-22-6 | |
2932190002 | |||
USP-1022808 | 2-Amino-5-chlorobenzophenone (25 mg) | 719-59-5 | |
2922390000 | |||
USP-1023403 | Diazepam Related Compound B (25 mg) (3-Amino-6-chloro-1-methyl-4-phenylcarbostyril) | 5220-02-0 | |
2933790002 | |||
USP-1038025 | Antazoline Related Compound A (15 mg) (N-(2-Aminoethyl)-2-[benzyl(phenyl)amino]acetamide) | 26953-37-7 | |
2924296000 | |||
USP-1040005 | Antipyrine (200 mg) | 60-80-0 | |
2933110000 | |||
USP-1040016 | Antipyrine Related Compound A (25 mg) (3-Methyl-1-phenyl-1H-pyrazol-5(4H)-one) | 89-25-8 | |
2933194350 | |||
USP-1040683 | Apigenin (30 mg) (5,7-Dihydroxy-2-(4-hydroxyphenyl)-4-benzopyrone) | 520-36-5 | |
2932996560 | |||
USP-1040708 | Apigenin-7-glucoside (30 mg) | 578-74-5 | |
2938900000 | |||
USP-1041008 | Apomorphine Hydrochloride (250 mg) | 41372-20-7 | |
2933997000 | |||
USP-1041609 | Apraclonidine Hydrochloride (100 mg) | 73218-79-8 | UN2811 |
USP-1041904 | Aprepitant (150 mg) | 170729-80-3 | UN3077 |
USP-1041915 | Aprepitant Related Compound A (10 mg) (3-[[(2R,3R)-2-[(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-5(4H)-one) | 1148113-53-4 | |
2934990005 | |||
USP-1041926 | Aprepitant Related Compound B (10 mg) (3-[[(2S,3R)-2-[(S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-5(4H)-one) | 172822-29-6 | |
2934990005 | |||
USP-1041992 | Desfluoro Aprepitant (15 mg) (5-{[(2R,3S)-2-{(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy}-3-phenylmorpholino]methyl}-2H-1,2,4-triazol-3(4H)-one) | 170729-76-7 | |
2934990005 | |||
USP-1042055 | Arabinose (50 mg) | 87-72-9 | |
2940006000 | |||
USP-1042102 | L-Arabinitol (250 mg) | 7643-75-6 | |
2905490000 | |||
USP-1042270 | Arachidyl Alcohol (125 mg) | 629-96-9 | |
2905199095 | |||
USP-1154514 | Cyclobenzaprine Related Compound A (10 mg) (5-[3-(dimethylamino)propyl]-5H-dibenzo[a,d]-cyclohepten-5-ol) | 18029-54-4 | |
2921490002 | |||
USP-1154525 | Cyclobenzaprine Related Compound B (10 mg) (3-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-N-methyl-1-propanamine, hydrochloride) | 438-59-5 | |
2921490002 | |||
USP-1154558 | Alpha Cyclodextrin (500 mg) | 10016-20-3 | |
2940006000 | |||
USP-1154569 | Beta Cyclodextrin (500 mg) | 7585-39-9 | |
2940006000 | |||
USP-1154591 | Gamma Cyclodextrin (200 mg) | 17465-86-0 | |
2940006000 | |||
USP-1154649 | Cyclohexanecarboxylic Acid (500 mg) | 98-89-5 | |
2916205000 | |||
USP-1156000 | Cyclopentolate Hydrochloride (300 mg) | 5870-29-1 | |
2922190900 | |||
USP-1157002 | Cyclophosphamide (500 mg) | 6055-19-2 | |
2934990005 | |||
USP-1157013 | Cyclophosphamide Related Compound A (25 mg) (bis(2-chloroethyl)amine hydrochloride) | 821-48-7 | |
2921196190 | |||
USP-1157024 | Cyclophosphamide Related Compound B (25 mg) (3-(2-chloroethyl)-2-oxo-2-hydroxy-1,3,6,2-oxadiazaphosphonane) | 158401-52-6 | |
2934990005 | |||
USP-1157035 | Cyclophosphamide Related Compound C (25 mg) (3-aminopropyl dihydrogen phosphate) | 1071-28-9 | |
2921196190 | |||
USP-1157046 | Cyclophosphamide Related Compound D (25 mg) (3-[2-(2-chloroethylamino)ethylamino]propyl dihydrogen phosphate dihydrochloride) | 158401-51-5 | |
2921290055 | |||
USP-1158005 | Cycloserine (250 mg) | 68-41-7 | UN3224 |
USP-1158504 | Cyclosporine (50 mg) | 59865-13-3 | |
2933790002 | |||
USP-1158650 | Cyclosporine Resolution Mixture (25 mg) (This material is an approximate 100:1 (w/w) mixture of cyclosporine and cyclosporine U) | N/A | |
3822190000 | |||
USP-1159008 | Cyclothiazide (200 mg) (AS) | 2259-96-3 | |
2935904000 | |||
USP-1161000 | Cyproheptadine Hydrochloride (500 mg) | 41354-29-4 | UN2811 |
USP-1161010 | Cyproheptadine Related Compound A (40 mg) (5H-dibenzo[a,d]cycloheptene) | 256-81-5 | |
2902909500 | |||
USP-1161032 | Cyproheptadine Related Compound C (25 mg) (5-(1-methyl-piperidin-4-yl)-5H-dibenzo[a,d]cyclohepten-5-ol) | 3967-32-6 | |
2914299000 | |||
USP-1161203 | Cyromazine (200 mg) | 66215-27-8 | |
2933690000 | |||
USP-1161509 | L-Cysteine Hydrochloride (600 mg) | 7048/4/6 | |
2930909215 | |||
USP-1161586 | Cystine (200 mg) | 56-89-3 | |
2930904990 | |||
USP-1191011 | Dicyclomine Related Compound A (40 mg) ([1,1′-Bi(cyclohexane)]-1-carboxylic acid) | 60263-54-9 | |
2916205000 | |||
USP-1191204 | Didanosine (200 mg) | 69655-05-6 | |
2934990005 | |||
USP-1191215 | Didanosine System Suitability Mixture (10 mg) | 69655-05-6 | |
3822190000 | |||
USP-1191226 | Didanosine Related Compound A (25 mg) (Hypoxanthine) | 68-94-0 | |
2934990005 | |||
USP-1191237 | Didanosine Related Compound B (25 mg) (2′,3′-dideoxyadenosine) | 4097-22-7 | |
2934990005 | |||
USP-1191554 | Didymin (30 mg) ((RS)-5-Hydroxy-2-(4-methoxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranoside) | 2418540-64-2 | |
2938900000 | |||
USP-1213136 | Dinoprostone Related Compound C (20 mg) ((E)-7-{(1R,2R,3R)-3-Hydroxy-2-[(S,E)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl}hept-5-enoic acid) | 36150-00-2 | |
2937500000 | |||
USP-1224959 | Dolasetron Mesylate (125 mg) | 878143-33-0 | |
2933997500 | |||
USP-1224960 | Dolasetron Mesylate Related Compound A (25 mg) (Hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3 (4H)-one, hydrochloride) | 148091-18-3 | |
2933999552 | |||
USP-1224970 | Donepezil-N-Oxide (20 mg) | 120013-84-5 | |
2933399095 | |||
USP-1224981 | Donepezil Hydrochloride (200 mg) | 884740-09-4 | UN2811 |
USP-1224992 | Donepezil Related Compound A (25 mg) ((E)-2-[(1-benzylpiperidin-4-yl)methylene]-5,6-dimethoxyindan-1-one) | 145546-80-1 | |
2933399095 | |||
USP-1225000 | Doxapram Hydrochloride (200 mg) | 7081-53-0 | UN2811 |
USP-1225022 | Doxapram Related Compound B (25 mg) (1-Ethyl-4-{2-[(2-hydroxyethyl)amino]ethyl}-3,3-diphenylpyrrolidin-2-one, hydrochloride) | 100106-91-0 | |
2933999552 | |||
USP-1231626 | Ecamsule Related Compound B (50 mg) (4-(Hydroxymethyl)benzoic acid) | 3006-96-0 | |
2918195000 | |||
USP-1231637 | Ecamsule Related Compound C (50 mg) (terephthalic acid) | 100-21-0 | |
2917360000 | |||
USP-1231648 | Ecamsule Related Compound D (50 mg) (((1SR,4RS)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic acid) | 5872/8/2 | UN3261 |
USP-1231659 | Ecamsule Related Compound E (25 mg) (sodium ((1SR,4SR,E)-3-(4-(hydroxymethyl)benzylidene)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate) | N/A | |
2914710000 | |||
USP-1231660 | Ecamsule Related Compound F (25 mg) (4-((E)-((1SR,4SR)-7,7-dimethyl-3-oxo-4-(sulfomethyl)bicyclo[2.2.1]heptan-2-ylidene)methyl)benzoic acid) | N/A | |
2918300000 | |||
USP-1231681 | Ecamsule Related Compound G (25 mg) (4-((E)-((1SR,4SR)-7,7-dimethyl-3-oxo-4-(sulfomethyl)bicyclo[2.2.1]heptan-2-ylidene)methyl)benzaldehyde, sodium salt) | N/A | |
2914710000 | |||
USP-1231706 | Powdered Echinacea Angustifolia Extract (1 g) | 84696-11-7 | |
1302190200 | |||
USP-1231717 | Powdered Echinacea Pallida Extract (1 g) | 97281-15-7 | |
1302190200 | |||
USP-1231728 | Powdered Echinacea Purpurea Extract (1 g) | 90028-20-9 | |
1302190200 | |||
USP-1231750 | Echinacoside (15 mg) | 82854-37-3 | |
2938900000 | |||
USP-1231808 | Econazole Nitrate (250 mg) | 24169-02-6 | |
2933290000 | |||
USP-1231830 | Econazole Related Compound A (15 mg) (1-(2,4-Dichlorophenyl)-2-(1H-imidazole-1-yl)ethanol) | 24155-42-8 | |
2933290000 | |||
USP-1231852 | Econazole Related Compound C (15 mg) (1-(4-Chlorobenzyl)-3-[(2RS)-2-[(4-chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]imidazolium chloride) | N/A | |
2933290000 | |||
USP-1232006 | Edetate Calcium Disodium (200 mg) | 6766-87-6 | |
2922498050 | |||
USP-1233009 | Edetate Disodium (200 mg) | 6381-92-6 | |
2922498050 | |||
USP-1233508 | Edetic Acid (200 mg) | 60-00-4 | |
2922498050 | |||
USP-1234001 | Edrophonium Chloride (200 mg) | 116-38-1 | |
2923900100 | |||
USP-1302178 | Guarana Seed Dry Extract (1 g) | NA | |
1302190200 | |||
USP-1302203 | Purified Guggul Extract (500 mg) | N/A | |
1301900190 | |||
USP-1302214 | Guggulsterone Z (25 mg) | 39025-23-5 | |
2914299000 | |||
USP-1302247 | Gymnemagenin (15 mg) | 22467-07-8 | |
2906195000 | |||
USP-1302258 | Native Gymnema Extract (1 g) | 90045-47-9 | |
1302190200 | |||
USP-1302509 | Halcinonide (200 mg) | 3093-35-4 | |
2937220000 | |||
USP-1302906 | Halobetasol Propionate (200 mg) | 66852-54-8 | |
2937220000 | |||
USP-1303002 | Haloperidol (200 mg) | 52-86-8 | UN2811 |
USP-1303013 | Haloperidol Related Compound A (10 mg) (4,4′-Bis[4-(p-chlorophenyl)-4-hydroxypiperidino]-butyrophenone) | 67987-08-0 | |
2933399095 | |||
USP-1303024 | Haloperidol Related Compound B (10 mg) (4-[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(2-fluorophenyl)butan-1-one) | 1391052-53-1 | |
2933399095 | |||
USP-1303057 | Haloperidol Decanoate (200 mg (需冷链运输) | 74050-97-8 | |
2933399095 | |||
USP-1336205 | Ifosfamide (500 mg) | 3778-73-2 | UN2811 |
USP-1336249 | Iloperidone (200 mg) | 133454-47-4 | |
2934990005 | |||
USP-1336250 | Iloperidone Related Compound A (20 mg) ([4′-(3-Chloropropoxy)-3′-methoxy]acetophenone) | 58113-30-7 | |
2914710000 | |||
USP-1336500 | Imidazole (200 mg) (1H-Imidazole) | 288-32-4 | UN2923 |
USP-1336806 | Imidurea (200 mg) | 39236-46-9 | |
2933210000 | |||
USP-1337004 | Iminodibenzyl (25 mg) (10,11-Dihydro-5H-dibenzo[b,f]azepine) | 494-19-9 | |
2933991200 | |||
USP-1337809 | Imipenem Monohydrate (100 mg) | 74431-23-5 | |
2941906000 | |||
USP-1338007 | Imipramine Hydrochloride (200 mg) | 113-52-0 | |
2933995800 | |||
USP-1338313 | Imiquimod (200 mg) | 99011-02-6 | |
2933997000 | |||
USP-1338324 | Imiquimod Related Compound A (25 mg) (1-Isobutyl-1H-imidazo[4,5-c]quinoline) | 99010-24-9 | |
2933998350 | |||
USP-1338335 | Imiquimod Related Compound B (25 mg) (1-Isobutyl-1H-imidazo[4,5-c]quinoline 5-oxide) | 99010-63-6 | |
2933998350 | |||
USP-1338346 | Imiquimod Related Compound C (25 mg) (4-Chloro-1-isobutyl-1H-imidazo[4,5-c]quinoline) | 99010-64-7 | |
2934990005 | |||
USP-1338357 | Imiquimod Related Compound D (25 mg) (1-Propyl-1H-imidazo[4,5-c]quinolin-4-amine) | 853792-81-1 | |
2933998350 | |||
USP-1338481 | Imipramine Pamoate (300 mg) | 10075-24-8 | |
2933996100 | |||
USP-1338801 | Indapamide (500 mg) | 26807-65-8 | |
2935904000 | |||
USP-1338812 | Indapamide Related Compound A (50 mg) (4-chloro-N-(2-methyl-1H-indol-1-yl)-3-sulfamoylbenzamide) | 63968-75-2 | |
2935909550 | |||
USP-1339000 | Indigotindisulfonate Sodium (750 mg) | 860-22-0 | |
3204120000 | |||
USP-1339178 | Indinavir (100 mg) | 180683-37-8 | |
2933595960 | |||
USP-1339189 | Indinavir System Suitability (100 mg) | 180683-37-8 | |
2933595960 | |||
USP-1340009 | Indocyanine Green (250 mg) | 3599-32-4 | |
2933998350 | |||
USP-1617430 | Sotalol Related Compound C (50 mg) (N-[4-[2-[(1-Methylethyl)amino]ethyl]phenyl]methanesulfonamide monohydrochloride) | 16974-42-8 | |
2935909550 | |||
USP-1617474 | Defatted Powdered Soy (2.5 g) | 68513-95-1 | |
3504001090 | |||
USP-1618003 | Spectinomycin Hydrochloride (200 mg) | 22189-32-8 | |
2941906000 | |||
USP-1618717 | Spinosin (15 mg) | 72063-39-9 | |
2938900000 | |||
USP-1619006 | Spironolactone (125 mg) | 1952/1/7 | |
2937290000 | |||
USP-1619017 | Spironolactone Related Compound A (100 mg) ((2’R)-3′,4′-Dihydro-5’H-spiro[androst-4,6-diene-17,2′-furan]-3,5′-dione) | 976-71-6 | |
2937290000 | |||
USP-1619028 | Spironolactone Related Compound B (30 mg) ((2’R)-7alpha-(Acetylthio)-5’H-spiro[androst-4-ene-17,2′-furan]-3,5′-dione) | 132458-33-4 | |
2937290000 | |||
USP-1619039 | Spironolactone Related Compound C (30 mg) ((2’R)-3′,4′-Dihydro-5’H-spiro[androst-4-ene-17,2′-furan]-3,5′-dione) | 976-70-5 | |
2932206000 | |||
USP-1619040 | Spironolactone Related Compound D (30 mg) ((2’R)-7alpha-(Acetyldisulfanyl)-3′,4′-dihydro-5’H-spiro[androst-4-ene-17,2′-furan]-3,5′-dione) | N/A | |
2937290000 | |||
USP-1619051 | Spironolactone Epimer Mixture (30 mg) (7-Epispironolactone approximately 56% and Spironolactone approximately 39% mixture) | N/A | |
2932206000 | |||
USP-1619094 | Spironolactone Related Compound I (30 mg) (S-[17alpha-(Ethoxymethyl)-17-hydroxy-3-oxoandrost-4-en-7alpha-yl]ethanethioate) | N/A | |
2937290000 | |||
USP-1620209 | Stavudine (250 mg) | 3056-17-5 | |
2934990005 | |||
USP-1620220 | Stavudine System Suitability Mixture (10 mg) | N/A | |
3822190000 | |||
USP-1621008 | Stearic Acid (500 mg) | 1957/11/4 | |
2915700100 | |||
USP-1621507 | Stearoyl Polyoxylglycerides (100 mg) | 9011-21-6 | |
3824994100 | |||
USP-1622000 | Stearyl Alcohol (125 mg) | 112-92-5 | |
2905170000 | |||
USP-1622044 | Stearylpyridinium Chloride (25 mg) (1-Octadecylpyridinium chloride) | 3165-81-9 | UN2811 |
USP-1622317 | Steviol Glycosides System Suitability (50 mg) | 91722-21-3 | |
2938900000 | |||
USP-1622408 | Stevioside (30 mg) | 57817-89-7 | |
2938900000 | |||
USP-1623003 | Streptomycin Sulfate (200 mg) | 3810-74-0 | |
2941205000 | |||
USP-1623386 | Compressible Sugar (200 mg) | N/A | |
1701994000 |
美国药典USP标准品CAS编号查询(二十九),USP标准物质代理
USP订购编号 | 美国药典,USP分析标准品,英文名称,规格 | CAS编号查询 | UN编号对照 |
USP-1225204 | Dopamine Hydrochloride (200 mg) | 62-31-7 | UN3077 |
USP-1225215 | Dopamine Related Compound A (30 mg) (5-(2-Aminoethyl)-2-methoxyphenol) | 3213-30-7 | |
2922299000 | |||
USP-1225226 | Dopamine Related Compound B (30 mg) (4-(2-Aminoethyl)-2-methoxyphenol hydrochloride) | 1477-68-5 | |
2922299000 | |||
USP-1225281 | Dorzolamide Hydrochloride (200 mg) | 130693-82-2 | |
2935904000 | |||
USP-1225292 | Dorzolamide Hydrochloride Related Compound A (20 mg) ((4R,6R)-4-(ethylamino)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-2-sulfonamide-7,7-dioxide, monohydrochloride) | 122028-36-8 | |
2935909550 | |||
USP-1225306 | Dorzolamide Related Compound D (30 mg) ((4S,6S)-4-Amino-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide hydrochloride) | 164455-27-0 | |
2935909550 | |||
USP-1225317 | Dorzolamide Related Compound B (15 mg) ((4RS,6SR)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide hydrochloride) | 120279-37-0 | |
2935909550 | |||
USP-1225419 | Doxazosin Mesylate (200 mg) | 77883-43-3 | |
2934990005 | |||
USP-1225420 | Doxazosin Related Compound A (20 mg) (N-1,4-Benzodioxane-2-carbonyl piperazine hydrochloride) | 70918-74-0 | UN2811 |
USP-1225441 | Doxazosin Related Compound B (20 mg) (6,7-dimethoxyquinazoline-2,4-dione) | 28888-44-0 | |
2933997500 | |||
USP-1225452 | Doxazosin Related Compound C (20 mg) (2-chloro-4-amino-6,7-dimethoxyquinazoline) | 23680-84-4 | |
2933599550 | |||
USP-1225463 | Doxazosin Related Compound D (20 mg) (1,4-benzodioxane-2-carboxylic acid) | 3663-80-7 | |
2932996560 | |||
USP-1225474 | Doxazosin Related Compound E (20 mg) (2,4-dichloro-6,7-dimethoxyquinazoline) | 27631-29-4 | |
2933599550 | |||
USP-1225485 | Doxazosin Related Compound F (15 mg) (N,N’-bis(1,4-benzodioxane-2-carbonyl)piperazine) | 617677-53-9 | |
2934990005 | |||
USP-1225496 | Doxazosin Related Compound G (15 mg) (4-Amino-6,7-dimethoxyquinazolin-2(1H)-one hydrochloride) (需冷链运输) | 134749-43-2 | |
2933599550 | |||
USP-1225500 | Doxepin Hydrochloride (500 mg) | 1229-29-4 | UN2811 |
USP-1225511 | Doxepin Related Compound A (50 mg) (dibenzo[b,e]oxepin-11(6H)-one) | 4504-87-4 | |
2932996560 | |||
USP-1225522 | Doxepin Related Compound B (50 mg) ((11RS)-11-[3-(dimethylamino)propyl]-6,11-dihydrodibenzo[b,e]oxepin-11-ol) | 4504-88-5 | |
2932996560 | |||
USP-1225533 | Doxepin Related Compound C (25 mg) ((E,Z)-3-(Dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine hydrochloride) | 2887-91-4 | |
2932996560 | |||
USP-1225703 | Doxorubicin Hydrochloride (50 mg) | 25316-40-9 | |
2941906000 | |||
USP-1225758 | Doxorubicinone (25 mg) ((8S,10S)-6,8,10,11-Tetrahydroxy-8-(hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione) | 24385-10-2 | |
2914500000 | |||
USP-1225984 | Doxycycline Monohydrate (100 mg) | 17086-28-1 | |
2941300000 | |||
USP-1226003 | Doxycycline Hyclate (200 mg) | 24390-14-5 | |
2941300000 | |||
USP-1226014 | Doxycycline Related Compound A (10 mg) ((4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide, monohydrochloride) | 41411-66-9 | |
2941300000 | |||
USP-1227006 | Doxylamine Succinate (300 mg) | 562-10-7 | |
2933399095 | |||
USP-1228009 | Drometrizole (25 mg) (2-(2H-Benzotriazol-2-yl)-p-cresol) | 2440-22-4 | |
2933997500 | |||
USP-1228010 | Drometrizole Trisiloxane (200 mg) | 155633-54-8 | |
2933997500 | |||
USP-1228029 | Drometrizole Trisiloxane Related Compound A (25 mg) (2-(2H-Benzotriazol-2-yl)-6-(isobuten-1-yl)-p-cresol) | 2170-37-8 | |
2933997500 | |||
USP-1228031 | Drometrizole Trisiloxane Related Compound B (25 mg) (2-(2H-Benzotriazol-2-yl)-6-(isobuten-3-yl)-p-cresol) | 98809-58-6 | |
2933997500 | |||
USP-1228053 | Drometrizole Trisiloxane Related Compound D (25 mg) (2-(2H-Benzotriazol-2-yl)-6-isobutyl-p-cresol) | N/A | |
2933997500 | |||
USP-1228530 | Dronedarone Hydrochloride (125 mg) | 141625-93-6 | UN3077 |
USP-1228541 | Dronedarone Related Compound A (25 mg) (N-{2-Butyl-3-[4-(3-butylaminopropoxy)benzoyl]benzofuran-5-yl}methanesulfonamide, hydrochloride) | 197431-02-0 | |
2932996560 | |||
USP-1228552 | Dronedarone Related Compound B (20 mg) ((5-Amino-2-butylbenzofuran-3-yl){4-[3-(dibutylamino)propoxy]phenyl}methanone, dihydrochloride) | 1309476-91-2 | |
2932996560 | |||
USP-1228563 | Dronedarone Related Compound C (20 mg) ((5-Amino-2-butylbenzofuran-3-yl)(4-hydroxyphenyl)methanone) | 1278585-68-4 | |
2932996560 | |||
USP-1228574 | Dronedarone Related Compound D (20 mg) ((2-Butyl-5-nitrobenzofuran-3-yl)(4-hydroxyphenyl)methanone) | 141645-16-1 | |
2932996560 | |||
USP-1229001 | Droperidol (250 mg) | 548-73-2 | |
2933995800 | |||
USP-1229409 | Drospirenone (200 mg) | 67392-87-4 | |
2937230000 | |||
USP-1229410 | Drospirenone Related Compound A (15 mg) (17-Hydroxy-6beta,7beta:15beta,16beta-dimethylene-3-oxo-17beta-pregn-4-ene-21-carboxylic acid, gamma-lactone) | 90457-65-1 | |
2932206000 | |||
USP-1229817 | Duloxetine Hydrochloride (100 mg) | 136434-34-9 | UN2811 |
USP-1229828 | Duloxetine Related Compound A (10 mg) ((R)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine hydrochloride) | 910138-96-4 | UN2811 |
USP-1229872 | Duloxetine Related Compound F (10 mg) ((S)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine hydrochloride) | N/A | |
2934990005 | |||
USP-1229922 | Dutasteride (200 mg) | 164656-23-9 | |
2937290000 | |||
USP-1229931 | Dutasteride Resolution Mixture (20 mg) | N/A | |
2937290000 | |||
USP-1230000 | Dyclonine Hydrochloride (200 mg) | 536-43-6 | UN2811 |
USP-1231003 | Dydrogesterone (200 mg) | 152-62-5 | UN3077 |
USP-1231502 | Dyphylline (200 mg) | 479-18-5 | |
2939590000 | |||
USP-1231604 | Ecamsule Triethanolamine (200 mg) | 92841-53-7 | |
2914710000 | |||
USP-1231615 | Ecamsule Related Compound A (50 mg) (1,4-Phenylenedimethanol) | 589-29-7 | |
2906290000 | |||
USP-1241619 | Erlotinib Related Compound A (25 mg) (4-(3-{[6,7-Bis(2-methoxyethoxy) quinazolin-4-yl]amino}phenyl)-2-methyl-3-butyn-2-ol hydrochloride) | 299912-59-7 | |
2933599550 | |||
USP-1241823 | Erythorbic Acid (50 mg) | 89-65-6 | |
2932206000 | |||
USP-1241903 | Erythritol (200 mg) | 149-32-6 | |
2905490000 | |||
USP-1242000 | Erythromycin (250 mg) | 114-07-8 | UN3077 |
USP-1242010 | Erythromycin B (100 mg) | 527-75-3 | |
2941500000 | |||
USP-1242021 | Erythromycin C (50 mg) | 1675-02-1 | |
2941500000 | |||
USP-1242032 | Erythromycin Related Compound N (50 mg) (N-Demethylerythromycin A) | 992-62-1 | |
2932206000 | |||
USP-1243002 | Erythromycin Estolate (200 mg) | 3521-62-8 | |
2941500000 | |||
USP-1245008 | Erythromycin Ethylsuccinate (200 mg) | 1264-62-6 | |
2941500000 | |||
USP-1247003 | Erythromycin Lactobionate (200 mg) | 3847-29-8 | |
2941500000 | |||
USP-1248006 | Erythromycin Stearate (200 mg) | 643-22-1 | |
2941500000 | |||
USP-1248218 | Erythropoietin (100 ug) | 113427-24-0 | |
2937190000 | |||
USP-1249202 | Escin (350 mg) | 11072-93-8 | |
2938900000 | |||
USP-1249406 | Escitalopram Oxalate (200 mg) | 219861-08-2 | |
2932996560 | |||
USP-1249417 | Escitalopram Related Compound A (10 mg) ((S)-4-[4-dimethylamino-1-(4-fluoropheny)-1-hydroxy-1-butyl]-3-hydroxymethylbenzonitrile hemi(+)-di-toluoyltartrate) | 128173-53-5 | |
2926900005 | |||
USP-1249701 | Esmolol Hydrochloride (100 mg) | 81161-17-3 | |
2922190900 | |||
USP-1249789 | Esomeprazole Magnesium (100 mg) | 217087-09-7 | |
2933399095 | |||
USP-1249790 | Esomeprazole Sodium (200 mg) | 161796-78-7 | |
2933399095 | |||
USP-1249803 | Esomeprazole Strontium (20 mg) | 934714-36-0 | |
2933399095 | |||
USP-1249916 | Estazolam Related Compound A (10 mg) (5-Chloro-2-(3-chloromethyl-4H-1,2,4-triazol-4-yl)-benzophenone) | 37945-06-5 | |
2933999552 | |||
USP-1250008 | Estradiol (500 mg) | 35380-71-3 | |
2937230000 | |||
USP-1250020 | Estradiol Related Compound B (10 mg) (1,3,5(10),6-estratetraen-3,17beta-diol) | 7291-41-0 | |
2937230000 | |||
USP-1250041 | Estradiol Related Compound C (15 mg) (1,3,5(10)-estratrien-3,17beta-diol-6-one) | 571-92-6 | |
2937230000 | |||
USP-1251000 | Estradiol Benzoate (250 mg) | 50-50-0 | |
2937230000 | |||
USP-1269174 | Famciclovir Related Compound A (20 mg) (2-[2-(2-Amino-9H-purin-9-yl)ethyl]propane-1,3-diol] hydrochloride) | 246021-75-0; 104227-86-3 (base | |
2933599550 | |||
USP-1269185 | Famciclovir Related Compound B (20 mg) [4-(2-Amino-9H-purin-9-yl)-2-(hydroxymethyl)butyl acetate] | 104227-88-5 | |
2933599550 | |||
USP-1269196 | Famciclovir Related Compound C (20 mg) (4-(2-amino-9H-purin-9-yl)-2-methylbutyl acetate) | 174155-70-5 | |
2933599550 | |||
USP-1269200 | Famotidine (125 mg) | 76824-35-6 | |
2935904000 | |||
USP-1269221 | Famotidine Related Compound B (25 mg) (3,5-Bis[2-[[2-[(diaminomethylene)amino]thiazol-4-yl]methylthio]ethyl]-4H-1,2,4,6-thiatriazine 1,1-dioxide) | 89268-62-2 | |
2934990005 | |||
USP-1286413 | Frovatriptan Succinate (200 mg) | 158930-17-7 | |
2933995500 | |||
USP-1286424 | Frovatriptan Related Compound A (20 mg) ((R)-3-Amino-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide) | N/A | |
2933997500 | |||
USP-1286504 | Fructose (125 mg) | 57-48-7 | |
1702500000 | |||
USP-1286606 | L-Fucose (200 mg) | 2438-80-4 | |
2940006000 | |||
USP-1286650 | Fulvestrant (200 mg) | 129453-61-8 | |
2937230000 | |||
USP-1286661 | Fulvestrant System Suitability Mixture (30 mg) | N/A | |
2937230000 | |||
USP-1295516 | Glyburide Related Compound A (25 mg) (4-[2-(5-chloro-2-methoxybenzamido)ethyl]benzenesulfonamide) | 16673-34-0 | |
2935909550 | |||
USP-1295527 | Glyburide Related Compound B (25 mg) (methyl-[[4-[2-[(5-chloro-2-methoxybenzoyl)-amino]ethyl]phenyl]sulfonyl]carbamate) (AS) | 21165-77-5 | |
2935909550 | |||
USP-1295662 | beta-Glycerylphosphorylcholine (25 mg) | 18418-25-2 | |
2923100000 | |||
USP-1295709 | Glyceryl Dibehenate (200 mg) (Glyceryl dibehenate) | N/A | |
2915900000 | |||
USP-1295724 | Glyceryl Distearate (500 mg) | 1323-83-7 | |
2915700100 | |||
USP-1295742 | Glyceryl Monooleate 90% (250 mg) | 25496-72-4 | |
2916155100 | |||
USP-1295764 | Glyceryl Monocaprylate (300 mg) | 26402-26-6 | |
2915900000 | |||
USP-1295775 | Glyceryl Mono and Dicaprylocaprate (300 mg) | 91744-32-0 | |
3824994100 | |||
USP-1295786 | L-alpha-Glycerylphosphorylcholine (300 mg) | 28319-77-9 | |
2923100000 | |||
USP-1295800 | Glycine (200 mg) | 56-40-6 | |
2922498050 | |||
USP-1295822 | L-alpha-Glycerophosphorylethanolamine (25 mg) | 33049-08-0 | |
2922199695 | |||
USP-1295844 | Glycitein (15 mg) | 40957-83-3 | |
2932996560 | |||
USP-1295855 | Glycitin (15 mg) | 40246-10-4 | |
2938900000 | |||
USP-1295866 | Glycyl-L-Glutamine (200 mg) | 211446-46-7 | |
2924190002 | |||
USP-1295877 | Glycyl-L-Tyrosine (200 mg) | 39630-46-1 | |
2924296000 | |||
USP-1295888 | Glycyrrhizic Acid (25 mg) | 1405-86-3 | |
2938900000 | |||
USP-1296009 | Glycopyrrolate (200 mg) | 51186-83-5 | |
2933997500 | |||
USP-1350002 | Isopropamide Iodide (200 mg) | 71-81-8 | |
2924296000 | |||
USP-1351005 | Isoproterenol Hydrochloride (125 mg) | 51-30-9 | |
2922504500 | |||
USP-1356869 | Lamivudine Resolution Mixture C (0.8 mg) | N/A | |
3822190000 | |||
USP-1356871 | Hydrogenated Lanolin (200 mg) | N/A | |
1505009000 | |||
USP-1356891 | Lauryl Alcohol (125 mg) | 112-53-8 | UN3077 |
USP-1356916 | Lansoprazole (150 mg) | 103577-45-3 | |
2933399095 | |||
USP-1356927 | Lansoprazole Related Compound A (25 mg) (2-({[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl}sulfonyl)benzimidazole) | 131926-99-3 | |
2933399095 | |||
USP-1356931 | Lansoprazole Related Compound B (25 mg) (2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-pyridin-2-yl]methyl]sulfanyl]-1H-benzimidazole monohydrate) | 1288338-69-1 | |
2933399095 | |||
USP-1356945 | Lauroyl Arginine (100 mg) (dodecanoylarginine hydrochloride) | N/A | |
2933194350 | |||
USP-1356949 | Lauric Acid (500 mg) | 143-07-7 | |
2915900000 | |||
USP-1356950 | Lauroyl Polyoxylglycerides 1500 (500 mg) | 121548-04-7 | |
3824994100 | |||
USP-1356960 | Leflunomide (200 mg) | 75706-12-6 | UN2811 |
USP-1356971 | Letrozole (200 mg) | 112809-51-5 | |
2933997500 | |||
USP-1356982 | Letrozole Related Compound A (25 mg) (4,4′-(1H-1,3,4-triazol-1-ylmethylene)dibenzonitrile) | 112809-52-6 | |
2933998350 | |||
USP-1357001 | L-Leucine (200 mg) | 61-90-5 | |
2922498050 | |||
USP-1357056 | Leflunomide Related Compound B (20 mg) (Z)-2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)but-2-enamide | 163451-81-8 | UN2811 |
USP-1357067 | Leflunomide Related Compound C (10 mg) (N-(3′-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide) | 61643-23-0 | |
2934990005 | |||
USP-1357125 | Lacosamide Related Compound B (30 mg) (2-Acetamido-3-(benzylamino)-3-oxopropyl acetate) | 1822463-67-1 | |
2924296000 | |||
USP-1357158 | Lacosamide S-Enantiomer (30 mg) ((S)-2-(Acetylamino)-N-benzyl-3-methoxypropanamide) | 175481-37-5 | |
2924296000 | |||
USP-1357170 | Lacosamide Related Compound F (30 mg) (2-Acetamido-N-benzyl-3-hydroxypropanamide) | 171623-02-2 | |
2924296000 | |||
USP-1357475 | Latanoprost (50 mg) | 130209-82-4 | |
2937500000 | |||
USP-1357486 | Latanoprost Related Compound A (50 mg) (Isopropyl (E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoate) | 913258-34-1 | |
2937500000 | |||
USP-1357497 | Latanoprost Related Compound B (25 mg) (Isopropyl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3S)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoate) | 145773-22-4 | |
2937500000 | |||
USP-1357533 | Latanoprost Related Compound E (25 mg) ((Z)-7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}-5-heptenoic acid) | 41639-83-2 | |
2937500000 | |||
USP-1358004 | Leucovorin Calcium (500 mg) | 1492-18-8 | |
2936299055 | |||
USP-1358784 | Levalbuterol Hydrochloride (200 mg) | 50293-90-8 | |
2922504500 | |||
USP-1358795 | Levalbuterol Related Compound A (30 mg) (4-(2-tert-Butylamino-ethyl)-2-hydroxymethyl-phenol) | 1823256-56-9 | |
2922504500 | |||
USP-1358809 | Levalbuterol Related Compound B (20 mg) (alpha-[{(1,1-Dimethylethyl)amino}methyl]-4-hydroxy-3-methyl-benzenemethanol) | 18910-68-4 | |
2922504500 | |||
USP-1358810 | Levalbuterol Related Compound C (30 mg) (alpha-[{(1,1-Dimethylethyl)amino}methyl]-4-hydroxy-3-(methoxymethyl)-benzenemethanol) | 18910-70-8 | |
2922504500 | |||
USP-1358820 | Levalbuterol Related Compound D (30 mg) (5-[2-(tert-Butylamino)-1-hydroxyethyl]-2-hydroxybenzaldehyde sulfate (2:1) (salt)) | 156339-88-7 (Free base) | |
2922504500 | |||
USP-1358831 | Levalbuterol Related Compound E (30 mg) (alpha-[{(1,1-Dimethylethyl)amino}methyl]-3-(ethoxy-methyl)-4-hydroxy-benzenemethanol) | 754926-25-5 | |
2922504500 | |||
USP-1358842 | Levalbuterol Related Compound F (30 mg) ((R)-1-[4-(Benzyloxy)-3-(hydroxymethyl)phenyl]-2-(tert-butylamino)ethan-1-ol) | 174607-68-2 | |
2922504500 | |||
USP-1358864 | Levalbuterol Related Compound H (10 mg) (4-[2-(tert-Butylamino)-1-methoxyethyl]-2-(hydroxymethyl)phenol acetate) | N/A | |
2922504500 | |||
USP-1359302 | Levamisole Hydrochloride (125 mg) | 16595-80-5 | UN2811 |
USP-1359404 | Levetiracetam (200 mg) | 102767-28-2 | |
2933790002 | |||
USP-1076159 | Bosentan Related Compound D (15 mg) (4,6-dichloro-5-(2-methoxyphenoxy)-2,2′-bipyrimidine) | 150728-13-5 | |
2935909550 | |||
USP-1076160 | Bosentan Related Compound E (15 mg) (4-(tert-butyl)benzenesulfonamide) | 6292-59-7 | |
2935909550 | |||
USP-1076206 | Powdered Black Cohosh Extract (1.5 g) | 84776-26-1 | |
1302190200 | |||
USP-1076250 | Boswellia Serrata Extract (1 g) | N/A | |
1302190200 | |||
USP-1076261 | 3-Acetyl-11-Keto-Beta-Boswellic Acid (20 mg) | 67416-61-9 | |
2918300000 | |||
USP-1076308 | Bleomycin Sulfate (15 mg) | 9041-93-4 | |
2941906000 | |||
USP-1076329 | Brilliant Black PN (50 mg) | 2519-30-4 | |
3204196100 | |||
USP-1076341 | Boric Acid (1 g) | 10043-35-3 | |
2810000000 | |||
USP-1076352 | Bretylium Tosylate (200 mg) | 61-75-6 | |
2923900100 | |||
USP-1096270 | Carbomer Copolymer (100 mg) | 138789-85-2 | |
3906906000 | |||
USP-1096281 | Carbomer Homopolymer (100 mg) | 151687-96-6 | |
3906906000 | |||
USP-1096407 | Carboplatin (100 mg) | 41575-94-4 | |
2843900000 | |||
USP-1096510 | Carglumic Acid Related Compound A (30 mg) ((S)-3-(2,5-dioxoimidazolidin-4-yl)propanoic acid) | 17027-50-8 | |
2933290000 |
美国药典USP标准品CAS编号查询(二十八),USP标准物质代理
USP订购编号 | 美国药典,USP分析标准品,英文名称,规格 | CAS编号查询 | UN编号对照 |
USP-1044582 | Atorvastatin Related Compound H (20 mg) (Lactone Impurity, 5-(4-Fluorophenyl)-1-{2-[(2R, 4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-2-isopropyl-N,4-diphenyl-1H-pyrrole-3-carboxamide) | 125995-03-1 | |
2934990005 | |||
USP-1044593 | Atorvastatin Related Compound I (20 mg) (tert-Butyl 2-((4R,6R)-6-{2-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]ethyl}-2,2-dimethyl-1,3-dioxan-4-yl)acetate) | 125971-95-1 | |
2934990005 | |||
USP-1044651 | Atovaquone (200 mg) | 95233-18-4 | UN3077 |
USP-1044662 | Atovaquone Related Compound A (25 mg) (cis-2-[4-(4-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone) | 137732-39-9 | |
2914790000 | |||
USP-1044800 | Atracurium Besylate (100 mg) | 64228-81-5 | UN2811 |
USP-1044913 | Atomoxetine S-Isomer (10 mg) ((S)-N-Methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine hydrochloride) | 82857-39-4 | UN2811 |
USP-1044990 | Atropine (50 mg) (1alphaH,5alphaH-Tropan-3alpha-ol (+/-)-tropate (ester)) | 51-55-8 | UN1544 |
USP-1045009 | Atropine Sulfate (500 mg) | 5908-99-6 | UN1544 |
USP-1045337 | Avobenzone (500 mg) | 70356-09-1 | |
2914500000 | |||
USP-1045520 | Azacitidine (150 mg) | 320-67-2 | UN3077 |
USP-1045539 | Azacitidine Related Compound A (25 mg) (4-Amino-1,3,5-triazin-2(1H)-one) | 931-86-2 | |
2933690000 | |||
USP-1045541 | Azacitidine Related Compound B (15 mg) (1-O-Acetyl-2,3,5-tri-O-benzoyl-Beta-D-ribofuranose) | 6974-32-9 | |
2934990005 | |||
USP-1045574 | Azacitidine Related Compound C (15 mg) (1-beta-D-Ribofuranosyl-3-guanylurea picrate) | 4336-46-3 | |
2940006000 | |||
USP-1048244 | Powdered Bacopa Extract (500 mg) | 93164-89-7 | |
1302190200 | |||
USP-1048255 | Balsalazide Disodium (200 mg) | 150399-21-6 | |
2927000000 | |||
USP-1048266 | Balsalazide Related Compound A (100 mg) ((E)-5-[(p-carboxyphenyl)azo]-2-salicylic acid, disodium salt) | N/A | |
2927000000 | |||
USP-1048277 | Balsalazide Related Compound B (25 mg) ((E)-5-((m-[(2-carboxyethyl)carbamoyl]phenyl)azo)-2-salicylic acid) | N/A | |
2927000000 | |||
USP-1048288 | Beta Glucan (1 g) (Beta Glucan from Baker’s Yeast (Saccharomyces cerevisiae) | 9012-72-0 | |
3913901000 | |||
USP-1048357 | Baicalein (50 mg) | 491-67-8 | |
2932996560 | |||
USP-1048368 | Baicalein 7-O-Glucuronide (50 mg) | 21967-41-9 | |
2938900000 | |||
USP-1048415 | Lagerstroemia speciosa Leaf Dry Extract (1g) | N/A | |
1302190200 | |||
USP-1048506 | Beclomethasone Dipropionate (200 mg) | 5534/9/8 | |
2937220000 | |||
USP-1048517 | Beclomethasone Dipropionate Related Compound A (25 mg) (9-Chloro-11Beta,17-dihydroxy-16Beta-methyl-3,20-dioxopregna-1,4-diene-21-yl propionate) | 69224-79-9 | |
2918992090 | |||
USP-1048543 | Beclomethasone Dipropionate Related Compound H (25 mg) (9-Chloro-11Beta,17-dihydroxy-16Beta-methyl-3,20-dioxopregna-1,4-diene-17-yl propionate) | 5534-18-9 | |
2918992090 | |||
USP-1048550 | Behenoyl Polyoxylglycerides (500 mg) | N/A | |
3824994100 | |||
USP-1048572 | Bemotrizinol (200 mg) | 187393-00-6 | |
2933690000 | |||
USP-1048583 | Bemotrizinol Impurity Mixture (100 mg) | N/A | |
3822190000 | |||
USP-1048619 | Benazepril Hydrochloride (125 mg) | 86541-74-4 | |
2933790002 | |||
USP-1048620 | Benazepril Related Compound A (25 mg) ((3R)-3-[[(1R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic acid, monohydrochloride) | 215447-89-5 | |
2933790002 | |||
USP-1048630 | Benazepril Related Compound B (15 mg) (2-[(S)-3-{[(R)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl]amino}-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl]acetic acid hydrochloride) | 86541-77-7 | |
2933790002 | |||
USP-1048641 | Benazepril Related Compound C (50 mg) ((S)-2-{[(S)-1-(Carboxymethyl)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-3-yl]amino}-4-phenylbutanoic acid) | 86541-78-8 | |
2933790002 | |||
USP-1048652 | Benazepril Related Compound D (15 mg) (3-(1-Ethoxycarbonyl-3-cyclohexyl-(1S)-propyl)amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine-1-acetic acid monohydrochloride) | N/A | |
2933790002 | |||
USP-1048663 | Benazepril Related Compound E (25 mg) (3-amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine-1-acetic acid, monohydrochloride) | N/A | |
2933790002 | |||
USP-1048674 | Benazepril Related Compound F (15 mg) (tert-Butyl-3-amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine-1-acetic acid) | 109010-60-8 | |
2933790002 | |||
USP-1048685 | Benazepril Related Compound G (15 mg) (需冷链运输) ((3-(1-Ethoxycarbonyl-3-phenyl-(1S)-propyl)amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine)-1-acetic acid, ethyl ester) | 103129-58-4 | |
2933790002 | |||
USP-1049000 | Bendroflumethiazide (200 mg) | 73-48-3 | |
2935904000 | |||
USP-1050009 | Benoxinate Hydrochloride (200 mg) | 5987-82-6 | |
2922504500 | |||
USP-1012595 | rAlbumin Human (6 mg) (Recombinant Human Albumin) (需冷链运输) | 70024-90-7 | |
3502900000 | |||
USP-1013909 | Alpha-Lactalbumin (400 mg) (需冷链运输) | 9051-29-0 | |
3502200000 | |||
USP-1032007 | Amphotericin B (125 mg) (需冷链运输) | 1397-89-3 | |
2941906000 | |||
USP-1065491 | Beta Carotene System Suitability (200 mg) (需冷链运输) | N/A | |
2934100000 | |||
USP-1696131 | Triptorelin Acetate (1.82 mg) (5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-tryptophyl-L-leucyl-L-arginyl-L-prolylglycinamide acetate salt) (需冷链运输) | 57773-63-4 | |
2937190000 | |||
USP-1696142 | Triptorelin Related Compound C (1.31 mg) (Triptorelin acid; 5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-tryptophyl-L-leucyl-L-arginyl-L-prolylglycine) | 129418-54-8 | |
2933998350 | |||
USP-1398009 | Methadone Hydrochloride CII (200 mg) | 1095-90-5 | UN2811 |
USP-1399001 | Methamphetamine Hydrochloride CII (125 mg) | 51-57-0 | UN2811 |
USP-1430724 | Methylnaltrexone Peak Identification Mixture CII (10 mg) (Methylnaltrexone Bromide containing about 0.1% methylnaltrexone related compound A) | N/A | |
3822190000 | |||
USP-1433008 | Methylphenidate Hydrochloride CII (125 mg) | 23655-65-4 | |
2933399095 | |||
USP-1434011 | Methylphenidate Hydrochloride Erythro Isomer Solution CII (0.5 mL) | N/A | UN1230 |
USP-1438001 | Methyltestosterone CIII (250 mg) | 58-18-4 | |
2937290000 | |||
USP-1443362 | Mibolerone CIII (200 mg) | 3704/9/4 | |
2937290000 | |||
USP-1559618 | Pregabalin CV (200 mg) | 148553-50-8 | |
2922498050 | |||
USP-1592205 | Quazepam CIV (200 mg) | 36735-22-5 | |
2933996500 | |||
USP-1611004 | Secobarbital CII (200 mg) | 76-73-3 | UN2811 |
USP-1620005 | Stanozolol CIII (200 mg) | 10418-03-8 | |
2937290000 | |||
USP-1643408 | Temazepam CIV (200 mg) | 846-50-4 | |
2933910000 | |||
USP-1645006 | Testolactone CIII (125 mg) | 968-93-4 | |
2937290000 | |||
USP-1646009 | Testosterone CIII (125 mg) | 58-22-0 | |
2937290000 | |||
USP-1646010 | Testosterone Related Compound A CIII (20 mg) (Androst-4-ene-3,17-dione) | 1963/5/8 | |
2937290000 | |||
USP-1647001 | Testosterone Cypionate CIII (200 mg) | 58-20-8 | |
2937290000 | |||
USP-1648004 | Testosterone Enanthate CIII (200 mg) | 315-37-7 | |
2937290000 | |||
USP-1648026 | Testosterone Enanthate Related Compound B CIII (50 mg) (Androst-4-en-3-one-17beta-yl hexanoate) | 10312-45-5 | |
2937290000 | |||
USP-1648081 | Testosterone Enanthate Related Compound H CIII (25 mg) (Androst-5-ene-3Beta,17Beta-diyl diheptanoate) | 162890-98-4 | |
2937290000 | |||
USP-1649007 | Testosterone Propionate CIII (200 mg) | 57-85-2 | |
2937290000 | |||
USP-1661002 | Thiopental CIII (250 mg) | 76-75-5 | |
2933595960 | |||
USP-1672600 | Tramadol Hydrochloride CIV (100 mg) | 36282-47-0 | UN2811 |
USP-1672610 | Tramadol Related Compound A CIV (25 mg) ((RS,SR)-1-(3-Methoxyphenyl)-2-(dimethylaminomethyl)cyclohexanol hydrochloride) | 73806-49-2 | UN2811 |
USP-1673828 | Trenbolone Acetate CIII (200 mg) (需冷链运输) | 10161-34-9 | UN3077 |
USP-1680506 | Triazolam CIV (200 mg) | 28911-01-5 | |
2933910000 | |||
USP-1724350 | Zaleplon CIV (200 mg) | 151319-34-5 | |
2933595960 | |||
USP-1724893 | Zolpidem CIV (10 mg) | 82626-48-0 | UN3077 |
USP-1724907 | Zolpidem Tartrate CIV (200 mg) (需冷链运输) | 99294-93-6 | |
2933996500 | |||
USP-1724951 | Zolpidem Impurities Mixture CIV (15 mg) | N/A | UN3077 |
USP-1729118 | Zopiclone R-Isomer CIV (10 mg) ((-)-(5R)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate) | 43200-80-2 (racemic mixture) | |
2933790002 | |||
USP-1445415 | Modafinil S-enantiomer CIV (国际冷链运输要求) (30 mg) ((S)-2-(Benzhydrylsulfinyl)acetamide) | 112111-47-4 | |
2930902000 | |||
USP-1010015 | N-Acylphosphatidylethanolamine (Soy) Ammonium (国际冷链运输要求) (20 mg) | NA | |
2923202000 | |||
USP-1076013 | Bivalirudin (5 mg) (国际冷链运输要求) | 128270-60-0 | |
2933995300 | |||
USP-1076024 | Asp9-Bivalirudin (1 mg) (国际冷链运输要求) | 1182140-65-3 | UN3244 |
USP-1076035 | [des-Glu13]-Bivalirudin (1 mg) (国际冷链运输要求) | 1107611-94-8 | |
2933998350 | |||
USP-1149004 | Corticotropin (5.8 Units/vial; 2 vials) (国际冷链运输要求) | 9002-60-2 | UN1759 |
USP-1011743 | Adapalene Related Compound D (25 mg) (4,4′-dimethoxy-3,3′-di(adamant-1-yl)biphenyl) | 932033-57-3 | |
2918992090 | |||
USP-1011754 | Adapalene Related Compound E (25 mg) (2,2′-binaphthyl-6,6′-dicarboxylic acid) | 932033-58-4 | |
2918992090 | |||
USP-1011878 | Adrenalone Hydrochloride (25 mg) | 62-13-5 | |
2922504500 | |||
USP-1011889 | Advantame (200 mg) | 714229-20-6 | |
2924296000 | |||
USP-1011890 | Advantame Acid (20 mg) (N-[N-[3-(3-hydroxy-4-methoxyphenyl)propyl]aspartyl]phenylalanine) | 713524-95-9 | |
2924296000 | |||
USP-1011958 | Aegle Marmelos Fruit Dry Extract (175 mg) | 482-44-0 | |
1302190200 | |||
USP-1012032 | Actein (20 mg) | 18642-44-9 | |
2938900000 | |||
USP-1012054 | Acyclovir Related Compound F (50 mg) (N-[9-[(2-Hydroxyethoxy)methyl]-6-oxo-6,9-dihydro-1H-purin-2-yl]acetamide) | 110104-37-5 | |
2933599550 | |||
USP-1012065 | Acyclovir (300 mg) | 59277-89-3 | |
2933595960 | |||
USP-1012076 | Acyclovir Related Compound A (50 mg) (2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl acetate) | 102728-64-3 | |
2933599550 | |||
USP-1012087 | Acyclovir Related Compound G (50 mg) (2-{[2-(Acetylamino)-6-oxo-1,6-dihydro-9H-purin-9-yl]methoxy}ethyl acetate) | 75128-73-3 | |
2933599550 | |||
USP-1012101 | Adenine (200 mg) | 73-24-5 | UN1544 |
USP-1012112 | S-Adenosyl-L-Homocysteine (50 mg) | 979-92-0 | |
2934990005 | |||
USP-1012123 | Adenosine (200 mg) | 58-61-7 | |
2934990005 | |||
USP-1012134 | Ademetionine Disulfate Tosylate (500 mg) (S-Adenosyl-L-Methionine Disulfate Tosylate) | 97540-22-2 | |
2934990005 | |||
USP-1012145 | Agigenin (25 mg) | 55332-76-8 | |
2932996560 | |||
USP-1012178 | 5′-Adenylic Acid (500 mg) | 61-19-8 | |
2934990005 | |||
USP-1012190 | Adipic Acid (100 mg) | 124-04-9 | |
2917121000 | |||
USP-1012203 | Agnuside (25 mg) | 11027-63-7 | |
2938900000 | |||
USP-1012214 | Agar (500 mg) | 9002-18-0 | |
1302310000 | |||
USP-1012288 | Carotenes (3 x 100 mg) | N/A | |
2106906798 | |||
USP-1012316 | S-Adenosyl-L-Methionine 1,4-Butanedisulfonate (250 mg) | 101020-79-5 | |
2934990005 | |||
USP-1012495 | Beta Alanine (100 mg) | 107-95-9 | |
2922498050 | |||
USP-1012509 | L-Alanine (200 mg) | 56-41-7 | |
2922498050 | |||
USP-1012517 | L-Alanyl-L-Glutamine (200 mg) | 39537-23-0 | |
2924190002 | |||
USP-1012531 | L-Alanyl-L-Alanine (200 mg) | 1948-31-8 | |
2924190002 | |||
USP-1012553 | Albendazole (200 mg) | 54965-21-8 | UN3077 |
USP-1012564 | Albuterol Related Compound I (20 mg) (4-[2-(tert-Butylamino)-1-hydroxyethyl]phenol) | 96948-64-0 | |
2922504500 | |||
USP-1012600 | Albuterol (200 mg) | 18559-94-9 | |
2922504500 | |||
USP-1012611 | Albuterol Related Compound F (15 mg) (4-[2-(tert-Butylamino)-1-ethoxyethyl]-2-(hydroxymethyl)phenol) | 1221742-55-7 | |
2922504500 | |||
USP-1623411 | Succinic Acid (300 mg) | 110-15-6 | |
2917192300 | |||
USP-1623422 | Succinic Acid Melting Point Standard (1 g) | 110-15-6 | |
2917197055 | |||
USP-1623502 | Succinylcholine Chloride (500 mg) | 6101-15-1 | UN2811 |
USP-1623580 | Sucrose Diacetate Hexaisobutyrate (1 mL) | 126-13-6 | |
2940006000 | |||
USP-1623604 | Succinylmonocholine Chloride (125 mg) | 5297-17-6 | |
2923900100 | |||
USP-1623615 | Sucrose Octaacetate (500 mg) | 126-14-7 | |
2940006000 | |||
USP-1623626 | Sucralose (400 mg) | 56038-13-2 | |
2932190002 | |||
USP-1623637 | Sucrose (100 mg) | 57-50-1 | |
1701994000 | |||
USP-1623659 | Sucromalt (200 mg) | 911432-63-8 | |
1702905000 | |||
USP-1623670 | Sulbactam (250 mg) (需冷链运输) | 68373-14-8 | |
2934990005 | |||
USP-1642824 | Tacrolimus 8-epimer (15 mg) (See USP Certificate for full Chemical Name) | 129212-35-7 | |
2934990005 | |||
USP-1642835 | Tacrolimus 8-propyl analog (15 mg) (See USP Certificate for full Chemical Name) | 104987-30-6 | |
2934990005 | |||
USP-1642857 | Tacrolimus System Suitability Mixture (10 mg) (A mixture consisting of tacrolimus, ascomycin and tacrolimus 8-propyl analog) | NA | UN2811 |
USP-1642879 | Tadalafil (200 mg) | 171596-29-5 | |
2934990005 | |||
USP-1642904 | Tagatose (200 mg) | 87-81-0 | |
2940006000 | |||
USP-1643281 | Racemic Tamsulosin Hydrochloride (50 mg) | 80223-99-0 | |
2935909550 | |||
USP-1643292 | Racemethionine (200 mg) | 59-51-8 | |
2930400000 | |||
USP-1643306 | Tamoxifen Citrate (200 mg) | 54965-24-1 | UN3077 |
USP-1643317 | Citrus reticulata Pericarp Dry Extract (1 g) | 8016-85-1 | |
1302190200 | |||
USP-1643328 | Tannic Acid (2 g) | 1401-55-4 | |
3201900000 | |||
USP-1643339 | Tanshinone IIA (20 mg) | 568-72-9 | |
2938900000 | |||
USP-1643340 | Tartaric Acid (1 g) | 87-69-4 | |
2918120000 |
美国药典USP标准品CAS编号查询(二十七),USP标准物质代理
USP订购编号 | 美国药典,USP分析标准品,英文名称,规格 | CAS编号查询 | UN编号对照 |
USP-1643361 | Taurine (100 mg) | 107-35-7 | |
2921196190 | |||
USP-1643383 | Tazobactam (200 mg) | 89786-04-9 | |
2941106000 | |||
USP-1643394 | Tazobactam Related Compound A (20 mg) ((2S,3S)-2-Amino-3-methyl-3-sulfino-4-(1H-1,2,3-triazol-1-yl)butyric acid) | 118175-11-4 | |
2933999552 | |||
USP-1643419 | Telmisartan (200 mg) | 144701-48-4 | UN3077 |
USP-1643420 | Telmisartan Related Compound A (20 mg) (1,7′-dimethyl-2′-propyl-1H,3’H-2,5′-bibenzo[d]imidazole monohydrate) | 1282554-35-1 | |
2933998350 | |||
USP-1643703 | Terconazole (200 mg) | 67915-31-5 | |
2934990005 | |||
USP-1643736 | Teniposide (200 mg) | 29767-20-2 | UN2811 |
USP-1643747 | Teniposide Related Compound A (10 mg) (4′-Demethylepipodophyllotoxin) | 6559-91-7 | |
2932996560 | |||
USP-1643962 | Teriparatide (1 mg) (需冷链运输) | 52232-67-4 | |
2937190000 | |||
USP-1643984 | Terminalia chebula Fruit Dry Extract (1 g) | N/A | |
1302190200 | |||
USP-1644003 | Terpin Hydrate (750 mg) | 2451/1/6 | |
2906195000 | |||
USP-1644319 | Temazepam Related Compound A (15 mg) (5-chloro-2-methylaminobenzophenone) | 1022-13-5 | |
2933999552 | |||
USP-1650028 | Tetracaine Related Compound C (25 mg) (Methyl 4-(butylamino)benzoate) | 71839-12-8 | |
2922493800 | |||
USP-1651654 | 2,3,5,4′-Tetrahydroxystilbene-2-O-Beta-D-Glucoside (50 mg) ((E)-2,4-dihydroxy-6-(4-hydroxystyryl)phenyl beta-D-glucopyranoside) | 82373-94-2 | |
2938900000 | |||
USP-1652001 | Tetrahydrozoline Hydrochloride (200 mg) | 522-48-5 | |
2933290000 | |||
USP-1652023 | Tetrahydrozoline Related Compound B (25 mg) (2-(1,2,3,4-Tetrahydronaphthalen-1-yl)-1H-imidazole) | 945389-41-3 | |
2933290000 | |||
USP-1652034 | Tetrahydrozoline Related Compound C (25 mg) (1,2,3,4-Tetrahydronaphthalene-1-carboxylic acid) | 1914-65-4 | |
2916399000 | |||
USP-1652045 | Tetrahydrozoline Related Compound D (25 mg) (2-(Naphthalen-1-yl)-4,5-dihydro-1H-imidazole hydrochloride) | 13623-57-9 (free base) | |
2933290000 | |||
USP-1652056 | Tetrahydrozoline Related Compound E (25 mg) (N-(2-Aminoethyl)-1,2,3,4-tetrahydronaphthalene-1-carboxamide) | 84460-89-9 | |
2924296000 | |||
USP-1652158 | Tetraxetan (50 mg) | 60239-18-1 | |
2933999552 | |||
USP-1652169 | Tetraxetan Related Compound A (25 mg) (2,2′,2″-[10-(2-Ethoxy-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl]triacetic acid) | 2101625-18-5 | |
2933999552 | |||
USP-1076363 | Brinzolamide (200 mg) | 138890-62-7 | |
2935904000 | |||
USP-1076374 | Brinzolamide Related Compound A (50 mg) ((S)-4-(Ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e] [1,2]thiazine-6-sulfonamide 1,1-dioxide), (Brinzolamide (S)-Isomer)) | 154127-19-2 | |
2935909550 | |||
USP-1076385 | Brinzolamide Related Compound B (50 mg) ((R)-4-Amino-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide oxalate) | N/A | |
2935909550 | |||
USP-1076400 | Brimonidine Tartrate (250 mg) | 70359-46-5 | UN2811 |
USP-1076419 | Brimonidine Related Compound A (50 mg) (5-Bromoquinoxalin-6-amine) | 50358-63-9 | |
2933997500 | |||
USP-1076421 | Brimonidine Related Compound B (50 mg) (1-(5-Bromoquinoxalin-6-yl)thiourea) | 842138-74-3 | |
2933997500 | |||
USP-1076454 | Brimonidine Related Compound E (15 mg) (2-(5-Bromoquinoxalin-6-yl)guanidine dihydrochloride) | N/A | |
2933998350 | |||
USP-1076501 | Bromocriptine Mesylate (150 mg) | 22260-51-1 | UN3077 |
USP-1077005 | Bromodiphenhydramine Hydrochloride (200 mg) | 1808-12-4 | |
2922190900 | |||
USP-1077708 | 8-Bromotheophylline (400 mg) | 10381-75-6 | |
2939590000 | |||
USP-1077774 | Broccoli Seed Dry Extract (350 mg) | N/A | |
1302190200 | |||
USP-1077887 | Bromperidol Decanoate (15 mg) | 75067-66-2 | |
2933399095 | |||
USP-1078008 | Brompheniramine Maleate (125 mg) | 980-71-2 | |
2933399095 | |||
USP-1078201 | Budesonide (200 mg) | 51333-22-3 | |
2937290000 | |||
USP-1086108 | Calcifediol (75 mg) | 63283-36-3 | UN2811 |
USP-1086141 | Calcipotriene (200 mg) | 112965-21-6 | UN2811 |
USP-1086152 | Calcipotriene Related Compound C (15 mg) ((5E,7E,22E,24S)-24-Cyclopropyl-9,10-secochola-5,7,10(19),22-tetraene-1alpha,3beta,24-triol) | 113082-99-8 | UN2811 |
USP-1086301 | Calcitriol (10 mg) (需冷链运输) | 32222-06-3 | UN2811 |
USP-1086334 | Calcium Acetate (500 mg) | 62-54-4 | |
2915299000 | |||
USP-1086356 | Calcium Ascorbate (200 mg) | 5743-28-2 | |
2936270000 | |||
USP-1086378 | Calcium Benzoate (200 mg) | 5743-30-6 | |
2916310002 | |||
USP-1086403 | Calcium Carbonate (1 g) | 471-34-1 | |
2836500000 | |||
USP-1086414 | Calcium Citrate (500 mg) | 5785-44-4 | |
2918150000 | |||
USP-1086425 | Calcium Citrate Malate (200 mg) | 142606-53-9 | |
2918195000 | |||
USP-1086436 | Calcium Chloride (1 g) | 10035-04-8 | |
2827200000 | |||
USP-1086447 | Calcium Cyclamate (200 mg) | 5897-16-5 (dihydrate); 139-06- | |
2929909000 | |||
USP-1086800 | Calcium Gluceptate (200 mg) | 29039-00-7 | |
2918195000 | |||
USP-1086822 | Calcium Gluconate Anhydrous (200 mg) | 299-28-5 | |
2918160000 | |||
USP-1086833 | Calcium Gluconate Monohydrate (200 mg) (Calcium D-Gluconate Monohydrate) | 66905-23-5 | |
2918160000 | |||
USP-1086866 | Calcium (-)-Hydroxycitrate (150 mg) | NA | |
2918195000 | |||
USP-1086877 | Calcium L-Threonate (500 mg) (Calcium (2R,3S)-2,3,4-trihydroxybutanoate) | 70753-61-6 | |
2918195000 | |||
USP-1086888 | Calcium Lactate (1 g) | 5743-47-5 | |
2918110002 | |||
USP-1086902 | Calcium Lactobionate (200 mg) | 110638-68-1 | |
2918195000 | |||
USP-1086935 | Calcium Levulinate (1 g) (AS) | 5743-49-7 | |
2918300000 | |||
USP-1095517 | Carbidopa Related Compound A (25 mg) (3-O-Methylcarbidopa) | 85933-19-3 | |
2928002500 | |||
USP-1096019 | Carbinoxamine Related Compound A (25 mg) ((4-Chlorophenyl)(pyridin-2-yl)methanone) | 6318-51-0 | |
2933399095 | |||
USP-1096021 | Carbinoxamine Related Compound B (25 mg) ((4-Chlorophenyl)(pyridin-2-yl)methanol) | 27652-89-7 | |
2933399095 | |||
USP-1096032 | Carbinoxamine Related Compound C (25 mg) (N,N-Dimethyl-2-[phenyl(pyridin-2-yl)methoxy]ethan-1-amine oxalate) | N/A | |
2933399095 | |||
USP-1304049 | Heparin Sodium System Suitability (50 mg) | N/A | |
3822190000 | |||
USP-1304130 | Low Molecular Weight Heparin for Boron Analysis (300 mg) | 9041/8/1 | |
3001900190 | |||
USP-1304377 | Hesperidin (200 mg) | 64726-90-5 | |
2938900000 | |||
USP-1305008 | Hexachlorophene (500 mg) | 70-30-4 | UN2875 |
USP-1305303 | Hexacosanol (100 mg) | 506-52-5 | |
2905199095 | |||
USP-1305507 | 2E, 4E-Hexadienoic Acid Isobutylamide (25 mg) | 65937-49-7 | |
2924190002 | |||
USP-1308307 | Hexylresorcinol (200 mg) | 136-77-6 | |
2907299000 | |||
USP-1308505 | L-Histidine (200 mg) | 71-00-1 | |
2933290000 | |||
USP-1308550 | L-Histidine Monohydrochloride Monohydrate (200 mg) | 5934-29-2 | |
2933290000 | |||
USP-1309009 | Histamine Dihydrochloride (250 mg) | 56-92-8 | |
2933290000 | |||
USP-1309911 | Powdered Holy Basil Extract (1 g) | 91845-35-1 | |
1302190200 | |||
USP-1310008 | Homatropine Hydrobromide (200 mg) | 51-56-9 | |
2939790000 | |||
USP-1311000 | Homatropine Methylbromide (250 mg) | 80-49-9 | |
2939800000 | |||
USP-1311500 | Coagulation Factor VIIa (2 x 1.15 mg) (Eptacog Alfa (Activated)) | 102786-61-8 | |
3002120090 | |||
USP-1313006 | Hydralazine Hydrochloride (200 mg) | 304-20-1 | UN2811 |
USP-1313210 | Hydrastine (10 mg) | 118-08-1 | |
2939800000 | |||
USP-1313254 | 4-Hydrazinylbenzenesulfonamide Hydrochloride (25 mg) | 17852-52-7 | |
2935909550 | |||
USP-1314009 | Hydrochlorothiazide (200 mg) | 58-93-5 | |
2935904000 | |||
USP-1316004 | Hydrocortisone (200 mg) | 50-23-7 | UN2811 |
USP-1317007 | Hydrocortisone Acetate (200 mg) | 1950/3/3 | |
2937290000 | |||
USP-1333058 | Hydroxyzine Related Compound A (25 mg) (1-[(4-Chlorophenyl)phenylmethyl]piperazine) | 303-26-4 | |
2933599550 | |||
USP-1334006 | Hydroxyzine Pamoate (500 mg) | 10246-75-0 | |
2933595960 | |||
USP-1335009 | Hyoscyamine Sulfate (125 mg) | 6835-16-1 | UN1544 |
USP-1335010 | Hyoscyamine Related Compound A (10 mg) (Norhyoscyamine Sulfate) | N/A | UN1544 |
USP-1335202 | Hyperoside (50 mg) | 482-36-0 | |
2938900000 | |||
USP-1335279 | Hypromellose Acetate Succinate (100 mg) | 71138-97-1 | |
3912390000 | |||
USP-1335304 | Hypromellose Phthalate (100 mg) | 9050-31-1 | |
3912390000 | |||
USP-1335417 | Ibandronate Sodium (200 mg) | 138926-19-9 | UN1759 |
USP-1335428 | Ibandronate Related Compound A (25 mg) (3-[Methyl(pentyl)amino]propanoic acid hydrochloride) | 625120-81-2 | |
2922498050 | |||
USP-1335508 | Ibuprofen (750 mg) | 15687-27-1 | |
2916399000 | |||
USP-1335596 | Ibuprofen Related Compound J (25 mg) (2-(4-Isobutyrylphenyl)propanoic acid) | 65813-55-0 | |
2917394000 | |||
USP-1335610 | Ibutilide Fumarate (100 mg) | 122647-32-9 | |
2935904000 | |||
USP-1335621 | Ibutilide Related Compound A (20 mg) (N-Ethyl-N-heptyl-4-[4-(methylsulfonamido)phenyl]-4-oxobutanamide) | 100632-58-4 | |
2935909550 | |||
USP-1335632 | Ibutilide Related Compound B (20 mg) (N-Ethyl-N-heptyl-4-hydroxy-4-[4-(methylsulfonamido)phenyl]butanamide) | 160087-98-9 | |
2935909550 | |||
USP-1335701 | Idarubicin Hydrochloride (50 mg) | 57852-57-0 | UN2811 |
USP-1336001 | Idoxuridine (250 mg) | 54-42-2 | |
2934990005 | |||
USP-1609024 | Salicylic Acid Related Compound B (100 mg) (4-hydroxyisophthalic acid) | 636-46-4 | |
2918290000 | |||
USP-1609534 | Salidroside (25 mg) (2-(4-Hydroxyphenyl)ethyl-Beta-D-glucopyranoside) | 10338-51-9 | |
2938900000 | |||
USP-1609589 | Salmeterol Resolution Check (15 mg) | N/A | |
2922504500 | |||
USP-1609590 | Salmeterol System Suitability (15 mg) (Mixture containing salmeterol xinafoate, salmeterol-N-alkyl and salmeterol related compound H) | N/A | |
3822190000 | |||
USP-1609603 | Salmeterol Xinafoate (150 mg) | 94749-08-3 | |
2922504500 | |||
USP-1609614 | Salmeterol Related Compound A (20 mg) (4-[1-Hydroxy-2-(4-phenylbutylamino)ethyl]-2-(hydroxymethyl)phenol) | N/A | |
2922504500 | |||
USP-1609625 | Salmeterol Related Compound B (3 x 1.3 mg) (4-{1-Hydroxy-2-[6-(4-phenylbutan-2-yloxy)hexylamino]ethyl}-2- | 108928-81-0 | |
2922504500 | |||
USP-1609680 | Salmeterol Related Compound H (30 mg) (1-Hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)benzyl]-2-naphthoic acid, monohydrate) | N/A | |
2922504500 | |||
USP-1609807 | Salsalate (150 mg) | 552-94-3 | |
2918230000 | |||
USP-1609818 | Salvianolic Acid B (25 mg) | 121521-90-2 | |
2938900000 | |||
USP-1609829 | Saquinavir Mesylate (200 mg) | 149845-06-7 | |
2933492250 | |||
USP-1609831 | Saquinavir Related Compound A (25 mg) (N-tert-butyl-decahydro-2-[2(R)-hydroxy-4-phenyl-3(S)-[[N-(2-quinolylcarbonyl)-D-asparaginyl]amino]butyl]-(4aS,8aS)-isoquinoline-3(S)-carboxamide) | N/A | |
2933497050 | |||
USP-1609840 | Saposhnikovia Divaricata Root Dry Extract (1 g) | NA | |
1302190200 | |||
USP-1609895 | Schisandrin (15 mg) | 7432-28-2 | |
2909490000 | |||
USP-1609909 | Schisandra chinensis Fruit Dry Extract (1 g) | N/A | |
1302190200 | |||
USP-1610001 | Scopolamine Hydrobromide (500 mg) | N/A | UN1544 |
USP-1610090 | Scopoletin (20 mg) | 92-61-5 | |
2932206000 | |||
USP-1610307 | Scutellaria Baicalensis Root Dry Extract (1 g) | N/A | |
1302190200 | |||
USP-1611117 | Secoxyloganin (50 mg) ([(2S,3R,4S)-2-(beta-D-Glucopyranosyloxy)-5-(methoxycarbonyl)-3-vinyl-3,4-dihydro-2H-pyran-4-yl]acetic acid) | 58822-47-2 | |
2938900000 | |||
USP-1611729 | Selamectin (350 mg) | 220119-17-5 | UN3077 |
USP-1611900 | Selegiline Hydrochloride (200 mg) | 14611-52-0 | |
2921490002 | |||
USP-1611944 | Selegiline Related Compound D (15 mg) ((R)-N-(1-Phenylpropan-2-yl)prop-2-yn-1-amine hydrochloride) | 115586-38-4 | |
2921490002 | |||
USP-1611955 | Selenomethionine (100 mg) | 3211-76-5 | |
2931909000 | |||
USP-1611966 | Selenium Sulfide (200 mg) | 7488-56-4 | |
2813906000 | |||
USP-1612007 | Sennosides (500 mg) | N/A | |
2938900000 | |||
USP-1612018 | Sennoside A (20 mg) ((9R,9’R)-5,5′-Bis(beta-d-glucopyranosyloxy)-4,4′-dihydroxy-10,10′-dioxo-9,9′,10,10′-tetrahydro-9,9′-bianthracene-2,2′-dicarboxylic acid) | 81-27-6 | |
2938900000 | |||
USP-1612029 | Sennoside B (20 mg) | 128-57-4 | |
2938900000 | |||
USP-1612415 | Sesame Oil Related Compound A (12 mg/vial; 2 vials) (1,2-dilinoleoyl-3-oleoyl-rac-glycerol) (OLL) | 2190-21-8 | |
1516200100 |
美国药典USP标准品CAS编号查询(二十六),USP标准物质代理
USP订购编号 | 美国药典,USP分析标准品,英文名称,规格 | CAS编号查询 | UN编号对照 |
USP-1098504 | Celecoxib (200 mg) | 169590-42-5 | |
2935904000 | |||
USP-1098515 | Celecoxib Related Compound A (10 mg) (4-[5-(3-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide) | 170570-01-1 | |
2935909550 | |||
USP-1098526 | Celecoxib Related Compound B (10 mg) (4-[3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide) | 331943-04-5 | |
2935909550 | |||
USP-1098537 | Celecoxib Related Compound C (25 mg) (4-[5-(2,4-Dimethylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide) | 170570-09-9 | |
2933194350 | |||
USP-1098570 | Celecoxib Related Compound D (25 mg) ((E)-4-{2-[1-(p-Tolyl)ethylidene]hydrazineyl}benzenesulfonamide) | 1061214-06-9 | |
2935909550 | |||
USP-1099008 | Cephalexin (400 mg) | 23325-78-2 | |
2941906000 | |||
USP-1099041 | Cephalexin Related Compound D (25 mg) (3-Hydroxy-4-methylthiophen-2(5H)-one) | 34876-35-2 | |
2934990005 | |||
USP-1099063 | Cephalexin Related Compound F (25 mg) ((6R,7R)-7-[(R)-2-Amino-2-phenylacetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid) | 79750-46-2 | |
2934990005 | |||
USP-1102408 | Cephapirin Benzathine (100 mg) | 97468-37-6 | |
2941906000 | |||
USP-1102500 | Cephapirin Sodium (500 mg) | 24356-60-3 | |
2941906000 | |||
USP-1102805 | Cephradine (300 mg) | 75975-70-1 | |
2941906000 | |||
USP-1102929 | Cetirizine Hydrochloride (250 mg) | 83881-52-1 | |
2933595960 | |||
USP-1102930 | Cetirizine Related Compound A (20 mg) ((RS)-2-[2-[4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]acetic acid ethyl ester oxalate) | 246870-46-2 | |
2933599550 | |||
USP-1102941 | Cetirizine Related Compound B (25 mg) (2-(4-Benzhydrylpiperazin-1-yl)ethan-1-ol dihydrochloride) | 108983-83-1 | |
2933599550 | |||
USP-1102952 | Cetirizine Related Compound C (25 mg) (2-(2-{4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl}ethoxy)acetamide) | 83881-37-2 | |
2933599550 | |||
USP-1133638 | Chromium Picolinate (100 mg) | 14639-25-9 | |
2933399095 | |||
USP-1133740 | Chrysanthemum Indicum Flower Dry Extract (500 mg) | N/A | |
1302190200 | |||
USP-1133751 | Chrysanthemum X Morifolium Flower Dry Extract (500 mg) | N/A | |
1302190200 | |||
USP-1133828 | Cimifugin (15 mg) | 37921-38-3 | |
2932996560 | |||
USP-1133842 | L-Citrulline (200 mg) | 372-75-8 | |
2924190002 | |||
USP-1133853 | Cidofovir (100 mg) | 149394-66-1 | |
2933599550 | |||
USP-1133864 | Cidofovir Enantiomer (15 mg) (1-[(R)-3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine dihydrate) | N/A | |
2933599550 | |||
USP-1133875 | Cidofovir Related Compound A (15 mg) (1-[(S)-3-Hydroxy-2-(O-ethylphosphonomethoxy)propyl]cytosine) | 1312776-50-3 | |
2933599550 | |||
USP-1133886 | Cidofovir Related Compound B (15 mg) (1-[(S)-3-Hydroxy-2-(O,O-diethylphosphonomethoxy)propyl]cytosine hydrochloride) | N/A | |
2933599550 | |||
USP-1133922 | Cinacalcet Related Compound C (50 mg) ((R)-N-[1-(Naphthalen-1-yl)ethyl]-3-[4-(trifluoromethyl)phenyl]propan-1-amine hydrochloride) | 1428118-39-1 | |
2921490002 | |||
USP-1133933 | Cinnamic Acid (100 mg) | 140-10-3 | |
2916399000 | |||
USP-1133966 | Cinacalcet Related Compound D (50 mg) ((S)-N-[1-(Naphthalen-1-yl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine hydrochloride) | 1217809-88-5 | |
2921490002 | |||
USP-1133977 | Cinacalcet Hydrochloride (250 mg) | 364782-34-3 | UN3077 |
USP-1134007 | Chymotrypsin (300 mg) (需冷链运输) | 9004/7/3 | |
3507907000 | |||
USP-1134018 | Ciclopirox (50 mg) | 29342-05-0 | UN3077 |
USP-1134029 | Ciclopirox Related Compound A (25 mg) (3-Cyclohexyl-4,5-dihydro-5-methyl-5-isoxazolyl acetic acid) | N/A | |
2934990005 | |||
USP-1134030 | Ciclopirox Olamine (125 mg) | 41621-49-2 | UN3077 |
USP-1134040 | Ciclopirox Related Compound B (25 mg) (6-Cyclohexyl-4-methyl-2-pyrone) | 14818-35-0 | |
2932206000 | |||
USP-1134051 | Cilastatin Ammonium Salt (100 mg) | 877674-82-3 | |
2930909265 | |||
USP-1134062 | Cimetidine (200 mg) | 51481-61-9 | |
2933290000 | |||
USP-1134073 | Cimetidine Hydrochloride (200 mg) | 70059-30-2 | |
2933290000 | |||
USP-1727097 | Zolmitriptan Related Compound H (50 mg) (4,4-Diethoxy-N,N-dimethylbutan-1-amine) | 1116-77-4 | UN3267 |
USP-1733119 | Meso-Zeaxanthin (5x 30 mg) (Beta-Beta-Carotene-3,3′-diol, (3R ,3′ S)-) | 31272-50-1 | |
3203000000 | |||
USP-1A00290 | Isopropyl 4-acetylbenzoate (需冷链运输) (25 mg) (Isopropyl 4-acetylbenzoate) | 220089-22-5 | |
2918300000 | |||
USP-1A00400 | Tetramethyl Ethylene Diamine (25 mg) (N1,N1,N2,N2-tetramethylethane-1,2-diamine) | 110-18-9 | UN2372 |
USP-1A00900 | 4-Methylacetophenone (1-(4-Methylphenyl)-1-ethanone (4′-Methylacetophenone)) | 122-00-9 | |
2914399000 | |||
USP-1A01310 | tert-Octylamine (25 mg) (2,4,4-trimethylpentan-2-amine) | 107-45-9 | UN2734 |
USP-1A01350 | Bis(2-methylaminoethyl) Ether (25 mg) (2,2′-oxybis(N,N-dimethylethan-1-amine)) | 3033-62-3 | UN2922 |
USP-1A01560 | Chlorothiophene Aldehyde (25 mg) (5-chlorothiophene-2-carbaldehyde) | 7283-96-7 | |
2934990005 | |||
USP-1559505 | Prednisone Tablets (30 tablets) | 1953/3/2 | |
2937210000 | |||
USP-1303750 | Hemoglobin Protease Substrate (100 g) (国际冷链运输要求) | 9008-02-0 | |
3002905250 | |||
USP-1071304 | Bile Salts (10 g) | NA | |
3822190000 | |||
USP-1133900 | Cinnamomum Cassia Twig Powder (5 g) | 84961-46-6 | |
1302190200 | |||
USP-1234410 | Elemental Impurities Class 1 and 2A Mixture (120 mL) | N/A | UN1789 |
USP-1234427 | Elemental Impurities Class 2B Mixture (120 mL) | N/A | UN1789 |
USP-1234431 | Elemental Impurities Class 3 Mixture (120 mL) | N/A | UN2031 |
USP-1356880 | Lanolin (20 g) | 8006-54-0 | |
1505009000 | |||
USP-1356905 | Lanolin Alcohols (5 g) | 8027-33-6 | |
1505009000 | |||
USP-1380502 | Memantine Hydrochloride (150 mg) | 41100-52-1 | |
2921300000 | |||
USP-1443825 | Skim Milk Powder (20 g) | N/A | |
402210000 | |||
USP-1443847 | Skim Milk Powder with Melamine – Level A (20 g) | N/A | |
402210000 | |||
USP-1443872 | Skim Milk Powder with Melamine – Level C (20 g) | N/A | |
402210000 | |||
USP-1443883 | Skim Milk Powder with Melamine – Level D (20 g) | N/A | |
402210000 | |||
USP-1443894 | Skim Milk Powder with Melamine – Level E (20 g) | N/A | |
402210000 | |||
USP-1500502 | Particle Count Set (2 blanks and 2 suspensions) | N/A | |
3903190000 | |||
USP-1612652 | Simethicone (50 g) | 8050-81-5 | |
3910000000 | |||
USP-1152825 | Cyclic Olefin Copolymer (3 strips, 2” x 2” x 1 mm each) | 26007-43-2 | |
3901905501 | |||
USP-1277252 | Fluoride Dentifrice: Sodium Fluoride/Silica (4.6 oz) | N/A | |
3822190000 | |||
USP-1277274 | Fluoride Dentifrice: Sodium Fluoride/Sodium Bicarbonate Powder (4 oz) | N/A | |
3822190000 | |||
USP-1277354 | Fluoride Dentifrice: Sodium Monofluorophosphate/Dicalcium Phosphate (4.6 oz) | N/A | |
3822190000 | |||
USP-1277423 | Fluoride Dentifrice: Sodium Monofluorophosphate (1500 ppm)/Silica (5.25 oz) | N/A | |
3822190000 | |||
USP-1277456 | Fluoride Dentifrice: Stannous Fluoride-Silica (4 oz) | N/A | |
3822190000 | |||
USP-1294839 | Gluten in Oat Flour Method Development Materials (7 x 50 g) | N/A | |
1104220000 | |||
USP-1311306 | Homopolymer Polypropylene (3 Strips, 2” x 2 1/2” each) | 9003-07-0 | |
3920200000 | |||
USP-1457844 | Near IR System Suitability (1 unit) (Dysprosium (Dy2O3), Erbium (Er2O3), Holmium (Ho2O3), talc [Mg3Si4O10(OH)2] (1:1:1:1 w/w)) | N/A | |
2846909000 | |||
USP-1535813 | Scaffold Human Dermis Reference Photomicrographs (CD) | N/A | |
8523494000 | |||
USP-1535824 | Bovine Acellular Dermal Matrix Reference Photomicrographs (CD) | N/A | |
8523494000 | |||
USP-1535835 | Cultured Rat Pheochromocytoma Reference Photomicrographs (CD) | N/A | |
8523494000 | |||
USP-1535846 | Graftskin Reference Photomicrographs (CD) | N/A | |
8523494000 | |||
USP-1535857 | Human Fibroblast-Derived Skin Substitute Reference Photomicrographs (CD) | N/A | |
8523494000 | |||
USP-1535868 | Cryopreserved Human Fibroblast-Derived Dermal Substitute Reference Photomicrographs (CD) | N/A | |
8523494000 | |||
USP-1546183 | Polycarbonate (3 Strips, 2” x 2 1/2” each) | 25766-59-0 | |
3907400000 | |||
USP-1546707 | High-Density Polyethylene (3 strips (2” x 2 1/2” each)) | 9002-88-4 | |
3920100000 | |||
USP-1546809 | Low-Density Polyethylene (3 strips) | 9002-88-4 | |
3920100000 | |||
USP-1546900 | Polyethylene Terephthalate (3 strips (2” x 2 1/2” each)) | 25038-59-9 | |
3921905050 | |||
USP-1546922 | Polyethylene Terephthalate G (PETG) (3 Strips) | 25640-14-6 | |
3921905050 | |||
USP-1613021 | Desiccant, Medium (2 pouches (approximate weight 80 grams, each)) | 1318-02-1 | |
3824999370 | |||
USP-1067001 | Betamethasone Acetate (500 mg) | 987-24-6 | UN2811 |
USP-1067034 | Betamethasone Acetate Related Compound C (20 mg) (9-Fluoro-11Beta,17,21-trihydroxy-16Beta-methylpregna-1,4-diene-3,20-dione 11,21-diacetate) | 330157-05-6 | |
2918992090 | |||
USP-1067045 | Betamethasone Acetate Related Compound D (20 mg) (9,11Beta-Epoxy-17,21-dihydroxy-16Beta-methylpregna-1,4-diene-3,20-dione 21-acetate) | 912-38-9 | |
2915399500 | |||
USP-1067307 | Betamethasone Benzoate (200 mg) | 22298-29-9 | UN2811 |
USP-1067704 | Betamethasone Dipropionate (125 mg) | 5593-20-4 | |
2937220000 | |||
USP-1067726 | Betamethasone Dipropionate Related Compound B (25 mg) (9-Fluoro-11Beta,21-dihydroxy-16Beta-methyl-3,20-dioxopregna-1,4-diene-17-yl propionate) | 5534-13-4 | |
2937220000 | |||
USP-1067737 | Betamethasone Dipropionate Related Compound C (25 mg) (9-Fluoro-11Beta,17-dihydroxy-16Beta-methyl-3,20-dioxopregna-1,4-diene-21-yl propionate) | 75883-07-7 | |
2937220000 | |||
USP-1067760 | Betamethasone Dipropionate Related Compound F (30 mg) (9,11Beta-Epoxy-16Beta-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropionate) | 66917-44-0 | |
2918992090 | |||
USP-1067781 | Betamethasone Dipropionate Related Compound H (30 mg) (6alpha-Bromo-9-fluoro-11Beta-hydroxy-16Beta-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropionate) | 1186048-34-9 | |
2918992090 | |||
USP-1068004 | Betamethasone Sodium Phosphate (500 mg) | 151-73-5 | UN2811 |
USP-1069007 | Betamethasone Valerate (200 mg) | 2152-44-5 | |
2937220000 | |||
USP-1069018 | Betamethasone Valerate Related Compound A (50 mg) (9-Fluoro-11beta,17-dihydroxy-16beta-methyl-3,20-dioxopregna-1,4-diene-21-yl valerate) | 2240-28-0 | |
2937220000 | |||
USP-1069095 | Betamethasone Valerate System Suitability Mixture (15 mg) (A mixture containing betamethasone valerate and betamethasone valerate related compound H) | NA | |
3822190000 | |||
USP-1069903 | Betaxolol Hydrochloride (200 mg) | 63659-19-8 | |
2922190900 | |||
USP-1069914 | Betaxolol Related Compound A (20 mg) (1-(4-Ethylphenoxy)-3-(isopropylamino)propan-2-ol) | 67193-95-7 | |
2922199695 | |||
USP-1071009 | Bethanechol Chloride (200 mg) | 590-63-6 | |
2924190002 | |||
USP-1071202 | Bicalutamide (200 mg) | 90357-06-5 | UN3077 |
USP-1071213 | Bicalutamide Related Compound A (25 mg) (N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluoro-phenyl)sulfinyl]-2-hydroxy-2-methyl-propanamide) | N/A | |
2930902000 | |||
USP-1071224 | Bicalutamide Related Compound B (10 mg) ((RS)-N-(4-Cyano-3-(trifluoromethyl)phenyl)-3-(3-fluorophenylsulfonyl)-2-hydroxy-2-methylpropanamide) | 1166228-30-3 | UN3077 |
USP-1071268 | Powdered Bilberry Extract (500 mg) | 84082-34-8 | |
1302190200 | |||
USP-1071381 | Biochanin A (20 mg) | 491-80-5 | |
2932992100 | |||
USP-1071508 | Biotin (200 mg) | 58-85-5 | |
2936299055 | |||
USP-1073423 | Biphenyl (500 mg) | 92-52-4 | UN3077 |
USP-1074007 | Bisacodyl (125 mg) | 603-50-9 | |
2933399095 | |||
USP-1074030 | Bisacodyl Related Compound A (20 mg) (4,4′-(Pyridin-2-ylmethylene)diphenol) | 603-41-8 | |
2933399095 | |||
USP-1074042 | Bisacodyl Related Compound B (20 mg) (2,4′-(Pyridin-2-ylmethylene)diphenol) | 16985-05-0 | |
2933399095 | |||
USP-1074051 | Bisacodyl Related Compound C (20 mg) (4-[(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenyl acetate) | 72901-16-7 | |
2933399095 | |||
USP-1074073 | Bisacodyl Related Compound E (20 mg) (2-[(4-Acetoxyphenyl)(pyridin-2-yl)methyl]phenyl acetate) | 111664-35-8 | |
2933399095 | |||
USP-1075305 | Bisdesmethoxycurcumin (30 mg) | 33171-05-0 | |
2914500000 | |||
USP-1075531 | Bismuth Citrate (100 mg) | 813-93-4 | |
2918150000 | |||
USP-1075553 | Bismuth Subsalicylate (100 mg) | 14882-18-9 | |
2918215100 | |||
USP-1075600 | Bismuth Subcarbonate (1 g) (AS) | 5892/10/4 | |
2836992000 | |||
USP-1075677 | Bisoctrizole (200 mg) | 103597-45-1 | |
2933997500 | |||
USP-1075688 | Bisoctrizole Related Compound A (25 mg) (2-(2H-Benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl) phenol) | 3147-75-9 | |
2933997500 | |||
USP-1075699 | Bisoctrizole Resolution Mixture (50 mg) | N/A | |
2933997500 | |||
USP-1075757 | Bisoprolol Fumarate (200 mg) | 104344-23-2 | |
2922190900 | |||
USP-1075768 | Bisoprolol Related Compound A (50 mg) (1-[4-(Hydroxymethyl)phenoxy]-3-(isopropylamino)propan-2-ol) | 62572-93-4 | |
2922199695 | |||
USP-1075780 | Bisoprolol Related Compound C (50 mg) (1-(Isopropylamino)-3-(4-methylphenoxy)propan-2-ol) | 5790-46-5 | |
2922199695 | |||
USP-1075799 | Bisoprolol Related Compound D (50 mg) (1-(4-{[(2-Isopropoxyethoxy)methoxy]methyl}phenoxy)-3-(isopropylamino)propan-2-ol fumarate (2:1) salt) | N/A | |
2922199695 | |||
USP-1075815 | Bisoprolol Related Compound F (50 mg) (2-Isopropoxyethyl 4-[2-hydroxy-3-(isopropylamino)propoxy]benzoate) | 864544-37-6 | |
2922504500 | |||
USP-1075870 | Bitter Orange Fruit Flavonoids Dry Extract (1 g) | N/A | |
2106906798 | |||
USP-1075892 | Bisphenol A (200 mg) | 1980/5/7 | UN3077 |
USP-1076115 | Bosentan (200 mg) | 157212-55-0 | |
2935909550 | |||
USP-1076126 | Bosentan Related Compound A (15 mg) (4-(tert-butyl)-N-[6-chloro-5-(2-methoxyphenoxy)-(2,2′-bipyrimidin)-4-yl] benzenesulfonamide) | 150727-06-3 | |
2935909550 | |||
USP-1076137 | Bosentan Related Compound B (15 mg) (4-(tert-butyl)-N-[6-hydroxy-5-(2-methoxyphenoxy)-(2,2′-bipyrimidin)-4-yl]benzenesulfonamide) | 174227-14-6 | |
2935909550 | |||
USP-1374226 | Magnesium Carbonate (2 g) | 23389-33-5 | |
2836999050 | |||
USP-1374248 | Magnesium Chloride (1 g) | 7791-18-6 | |
2827310000 | |||
USP-1374259 | Magnesium Citrate (500 mg) | 3344-18-1 | |
2918150000 | |||
USP-1379140 | Meglumine (500 mg) | 6284-40-8 | |
2922199695 | |||
USP-1379172 | Megestrol Acetate Related Compound H (20 mg) | 907193-65-1 | |
2915399500 | |||
USP-1379183 | Melamine (250 mg) (2,4,6-Triamino-1,3,5-triazine) | 108-78-1 | |
2933610000 | |||
USP-1379265 | Melengestrol Acetate Related Compound A (25 mg) (16-Methylene-3,20-dioxopregn-4-en-17-yl acetate) | 6815-51-6 | |
2937230000 | |||
USP-1379276 | Melengestrol Acetate Related Compound B (25 mg) (6,16-Dimethylene-3,20-dioxopregn-4-en-17-yl acetate) | 80097-73-0 | |
2937230000 | |||
USP-1379300 | Melphalan Hydrochloride (200 mg) | 1465-26-5 | UN2811 |
USP-1379401 | Meloxicam (400 mg) | 71125-38-7 | UN2811 |
USP-1379412 | Meloxicam Related Compound A (25 mg) (ethyl-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate- 1,1-dioxide) | 24683-26-9 | |
2934990005 | |||
USP-1379423 | Meloxicam Related Compound B (25 mg) (5-Methylthiazol-2-amine) | 7305-71-7 | UN3077 |
USP-1379434 | Meloxicam Related Compound C (30 mg) (Isopropyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate-1,1-dioxide) | N/A | |
2934990005 | |||
USP-1379445 | 4-Methoxymeloxicam (30 mg) (4-methoxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide) | 1391051-96-9 | |
2934100000 | |||
USP-1379456 | (Z)-N’-Methylmeloxicam (30 mg) ((Z)-N-(3,5-dimethylthiazol-2(3H)-ylidene)-4-hydroxy-2-methyl-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide) | 1145656-36-5 | |
2934990005 | |||
USP-1379605 | Mefenamic Acid (200 mg) | 61-68-7 | |
2922492050 | |||
USP-1380105 | Melatonin (150 mg) | 73-31-4 | |
2937909000 | |||
USP-1380116 | Melatonin Related Compound A (15 mg) (2-(5-methoxy-1H-indol-3-yl)ethanamine) | 608-07-1 | |
2933998350 | |||
USP-1380524 | Memantine Related Compound B (15 mg) (3,5-Dimethyladamantane-1-ol) | 707-37-9 | |
2906195000 | |||
USP-1380557 | Memantine Related Compound E (15 mg) (N-3,5-Dimethyladamantan-1-yl formamide) | 351329-88-9 | |
2924299500 | |||
USP-1380568 | Memantine Related Compound F (50 mg) (3-Amino-5,7-dimethyladamantan-1-ol hydrochloride) | 356572-08-2 | |
2922199695 |